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Cardiac transplantation was carried out on four patients at the
Medical College of Virginia between May and October of 1968,
in an effort to salvage them from
the terminal stages of otherwise
uncorrectable heart disease. Despite
a strikingly good early recovery
from operation in each case, three
of the patients died of acute homograft rejection in one to three
weeks; our second case is living and
well, ten months after operation,
and is at this writing the world's
third longest survivor. The world
experience to June of 1969 includes
about 130 cardiac transplants. Of
the first 100 patients operated on
over six months ago, 20 are surviving, and the majority of these
have returned to a productive existence, demonstrating the feasibility
of complete rehabilitation of at least
some terminal patients after cardiac transplantation. The high mortality rate-significantly higher than
was anticipated-has resulted from
acute and chronic homograft rejection and from the equally difficult problem of infection. Certain
lessons have been learned from our
own experience and from the world

* Pri;:sented in part by Dr. Lower at
the Fortieth Annual McGuire Lecture
Series, October 31-November 1, 1968,
Medical College of Virginia, Richmond.
t Supported by research grants from
the American Heart Association, the
Richmond Heart Association and the
National Heart Institute.
MCV QUARTERLY 5(4): 167-170, 1969

experience with this procedure, and
these will be reviewed in an attempt to establish the current status
and future potential of cardiac
transplantation.
Background: Animal
Experimentation

The information gained from ten
years of our laboratory experience
in part set the stage for the clinical
trials of cardiac transplantation initiated by Barnard in December of
1967. These investigations were begun first in the laboratories of Dr.
Norman E. Shumway of Stanford
University and later continued at
the Medical College of Virginia.
The feasibility of the procedure was
first established in December of
1959 when dogs were shown to recover completely after orthotopic
homotransplantation of the heart
(Lower and Shumway, 1960;
Lower, Stofer and Shumway, 1961).
The animals lived from 4 to 21
days without immunosuppressive
therapy and exhibited remarkably
normal activity until death from
rejection supervened, providing
convincing evidence that the transplanted heart could recover excellent function despite the interruption of nerves and lymphatics. In
a subsequent study two dogs recovered after transplantation of the
heart and both lungs (Lower et al.,
1961). The animals died after five
days, but showed normal ventilation and gas exchange prior to the
onset of rejection.
167
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Further laboratory studies
(Lower, Dong and Shumway,
1965a,b; Lower, Dong and Glazener, 1966) revealed that the most
sensitive and reliable test for impending cardiac rejection was a fall
in the QRS voltage on the electrocardiogram, often with the additional finding of abnormal intraventricular conduction. With the
advent of immunosuppressive
drugs, specifically azathioprine and
methylprednisolone, survival of animals was prolonged by treating
each recognized rejection crisis
with transiently high doses of the
drugs which were then tapered to
lower maintenance doses in an attempt to diminish the high incidence of toxicity and infection. A
few animals survived more than a
year and provided a significant
stimulus to the subsequent clinical
application of cardiac transplantation. Extensive physiologic tests of
the transplanted heart revealed that,
although function was often depressed for the first 24 to 48 hours,
thereafter cardiac output, even in
response to stress, was remarkably
adequate (Dong et al., 1965). In
some animals made to breathe 7 %
oxygen, cardiac outputs could be
markedly increased (Kontos and
Lower, 1969).
Evidence of autonomic reinnervation was seen in the majority of
transplants within a few months after operation and was confirmed
by appropriate immediate responses
to direct electrical stimulation of
vagal and sympathetic nerves
(H. A. Kontos, M. D. Thames
and R. R. Lower, unpublished
data). The return of sinus arrhythmia was also seen as a useful indicator of vagal reinnervation
(Thames, Kontos and Lower,
1969), and the ability of the heart
to respond reflexly to peripheral hypertension also reappeared (H. A.
Kontos et al., unpublished data).
Recently, fluorescent staining of
sympathetic fibers has confirmed
their regeneration within the graft
after several months.+
Although these observations fos168

tered considerable enthusiasm concerning the application of cardiac
transplantation to human disease,
this enthusiasm was tempered by
certain additional observations. In
about 25 % to 30 % of acute rejection crises, it was difficult or impossible to control the rejection process with drugs. Where continuous
or high dose immunosuppression
was needed, infection was often inevitable. Moreover, on histologic
examination of animals surviving
over three months, all showed some
evidence of compromise of coronary arterial lumens by thickening of the intimal layer. In some
of the longest surviving cases a few
of the coronary arteries were nearly
occluded. These findings were presented in 1967 (Lower and Cleveland, 1968), but it was out hope
that improved methods of histocompatibility matching along with
better drugs for immunosuppression, such as antilymphocyte globulin, might make cardiac transplantation in man less susceptible
to both acute and chronic rejection. Unfortunately these aims have
not been entirely realized.
Selection of Recipients
and Donors
The selection of patients for
cardiac transplantation has generally been reserved for those in the
terminal stage of their illness with
no alternative hope for recovery.
This policy is attested to by the
large numbers of patients who have
died in our hospital and elsewhere
while awaiting a suitable heart
donor. In the Stanford series, for
example, the mean survival of patients accepted for transplantation,
but for whom no suitable donor
could be obtained, has been four
weeks, with a maximal survival of
12 weeks (N. E. Shumway, personal communication).

:j: Studies performed by Dr. John E.
Norvell, Department of Anatomy,
Medical College of Virginia.

Two of our patients had sustained multiple myocardial infarctions with the subsequent development of refractory heart failure.
The other two patients had cardiomyopathy of undetermined etiology
with severe biventricular failure.
Cardiac catheterization in each case
revealed pulmonary hypertension,
elevation of the left ventricular end
diastolic pressure, low cardiac output and extremely poor contractility of the left ventricle. The patients
were all considered to have no alternative hope for recovery from
their cardiac disease and were,
therefore, accepted for cardiac
transplantation.
The selection of donors required
the establishment of irretrievable
brain death by an independent
team of neurosurgeons and neurologists. Brain death in these cases
was caused by extensive intracerebral hemorrhage or by massive
brain trauma. The criteria included
no pupillary reaction, absence of
spontaneous respiration or movements, absence of reflexes and an
isoelectric electroencephalogram.
The heart in the donor invariably
required vasopressors for support
and had usually sustained one or
more episodes of arrest. It is of
interest that, despite its failing
status in the donor, the heart in
each case adequately supported the
circulation in the recipient as soon
as coronary blood flow was reestablished.
Prospective histocompatibility
typing by the microlymphocytotoxicity techniques of Terasaki was
carried out in each case. However,
despite an excellent match with no
demonstrable major incompatibility
in the first case, the patient died of
acute fulminating rejection at one
week and was the first patient in
the world experience to die from
this cause. The course in this patient illustrated that typing, as current y practised, does not in fact
detect, with sufficient sensitivity,
all forms of incompatibility. The
second patient, however, was also
an excellent match; and, although
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he has sustained three rejection episodes, each one responded well to
a temporary increase in immunosuppressive therapy, and he remains well.
The third patient in this series
demonstrated a principle which
may continue to receive increased
attention in the preoperative matchings of potential recipients. Despite
the absence of preformed antibodies detected by the routine preoperative serum-lymphocyte cross
match, retrospective studies of the
patient's serum by the technique of
immune adherence established that
some degree of prior sensitization
did exist, as antibodies were present
against cultured kidney cells from
the same donor. The patient's clinical course was characterized by a
fulminating rejection episode at one
week which was unresponsive to
massive immunosuppressive therapy. The fourth patient, mismatched for histocompatibility antigen HLA-3, initially responded to
therapy for a rejection episode at
one week, but subsequently became
refractory to treatment and died of
rejection at 18 days. Antibody was
eluted from the heart postmortem
in each of the three fatal cases. The
possible role of antibody in acute
cardiac rejection has been discussed
further in another report (G. M.
Williams et al., unpublished data).
Surgical Techniq ue

The basic surgical technique
which proved successful in animal
transplantation (Lower et al.,
1961) was employed in our own
cases and has been generally utilized
by other transplant surgeons with
few modifications. The posterior
atrial wall, containing the openings
of the vena cavae and pulmonary
veins, is retained in the recipient to
facilitate anastomosis of the donor
heart. Anastomosis of the aorta
and pulmonary artery in the supravalvular region completes the procedure. Surgeons have varied most
in their management of the donor
heart. In our own cases the donor

heart was cooled by immersion in
saline at 8 to 10 C to afford the
myocardium protection during the
60 to 90 minutes that coronary circulation was interrupted and no
coronary perfusion was used.

most useful in the treatment of a
difficult rejection crisis or where
there are wide histocompatibility
differences.

Postopera tive Management

The early detection of a rejection
crisis requires close monitoring of
the electrocardiogram on at least a
daily basis for the first few months.
The primary signs of impending
rejection are a decrease in the QRS
voltage, a rightward shift in the
frontal plane axis, delayed intraventricular conduction and atrial or
nodal arrhythmias. Rejection is
characterized clinically by the insidious onset of right heart failure
as evidenced by weight gain, edema,
venous distention with increased
pulsations, right ventricular gallop,
and, eventually, the development of
murmurs of relative tricuspid or
mitral insufficiency. Early in the
course of rejection the lung fields
appear radiographically clear and
even oligemic, in reflecting the predominant right heart failure. Thus,
it is suggested that digitalis preparations and diuretics be discontinued as soon as is practical after
operation to avoid masking this important collateral evidence of impending rejection.
While serum enzyme abnormalities do occur with some rejection
episodes (particularly elevation of
the lactic dehydrogenase isozymes I
and II and the creatine phosphokinase), these abnormalities occur as
a late manifestation of rejection
and indicate a more severe degree
of myocardial injury. It is apparent
from our own observations and the
experience of others that a typical
rejection crisis can occur and be
diagnosed by other clinical and
ECG criteria without detectable abnormalities in the serum enzymes.
However, enzyme levels were
markedly elevated in the terminal
stages of each of the fatal rejection
episodes in our patients.
The other nonspecific signs and
symptoms occurring in conjunction
with rejection, such as pericardia!

Postoperative management of the
recipient has varied little from the
care of the routine cardiac surgery
patient with the exceptions that immunosuppressive therapy is administered in an effort to prevent rejection, and monitoring efforts are
directed toward the early detection
of a rejection crisis (Lower et al.,
1968; Sewell, Kemp and Lower,
1969). It now seems apparent that
the cardiac transplant recipient has
an immunologic capability that is
less impaired than the chronically
uremic renal transplant patient, and
the cardiac patient, therefore, requires more intensive immunosuppression, at least in the initial weeks,
to control rejection. This was not
appreciated early in our experience
but has evolved as the world results
have been discussed. The current
recommendations which have received widest acceptance are that
the recipient be given azathioprine
in the largest dose tolerated, usually
3 to 4 mg/ kg, and prednisone in a
dose of 200 mg/ day during the
initial two to three weeks. Drugs
are later tapered to a lower maintenance dose to decrease the risk of
infection and the other side effects
of steroid administration.
The role of antilymphocyte globulin is less clearly established. Some
patients have been managed successfully without it; others have developed fatal, acute or chronic rejection despite its use. The optimal
preparation, route of administration and dose have not been agreed
upon. Some patients reportedly
have rapidly developed antibodies
against the horse globulin with evidence that its immunologic effectiveness is rapidly dissipated (Butler et al., 1969). A few investigators have therefore considered it

Early Detection of Rejection
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friction rub, fever, leukocytosis and
malaise, can all occur with other
postoperative complications, e.g.,
infection, embolism or the various
post-perfusion syndromes, and are
thus of limited value in the diagnosis of impending rejection.

populated by host cells has yet to
be established . More precise histocompatibility matching and more
effective immunosuppression would
at the moment seem to offer the
best insurance against loss of the
graft due to chronic rejection.

Treatment of Acute Rejection
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The Role of Preservation m Transplantation*
FOLKERT 0. BELZER

Department of Surgery, University of California, San Francisco
Medical Center, San Francisco 94122

Introduction
Let us look first into the advantages and disadvantages of preservation in clinical transplantation.
I should mention that we are talking of short-term preservation up
to 72 hours, rather than preservation for indefinite periods of time.
The latter will have to wait until
problems of freezing and thawing
have been solved, but this still appears to be something for the distant future. What, then, are the advantages?
First, it minimizes the total
anoxia time. Although it is well
known that human cadaver kidneys
can maintain viability up to ten
hours by simple hypothermia, it is
our feeling that this is not good
enough. In cadaver kidneys, the
organ is already damaged during
the agonal period of the donor,
and the additional cold storage time
undoubtedly further damages the
organ, perhaps permanently. Furthermore, if preservation for more
than ten hours is necessary, some
method of perfusion is needed.
Second, it allows potential recipients to stay at home either on
central dialysis or chronic dialysis
until a properly matched kidney
becomes available. The patients actually do not have to be called until
a matched kidney is known to be
present, thus eliminating unnecessary admissions and great disappointments. Furthermore, if the potential recipient cannot be reached

* Presented at the Fortieth Annual
McGuire Lecture Series, October 31November 1, 1968, Medical College
of Virginia, Richmond.
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immediately, he is still not excluded
from receiving that particular kidney. It, of course, allows the total
recipient pool to be tremendously
increased, because patients who are
dialyzed in different centers or in
different cities can be selected by
computer and can be considered
for a transplantation.
Third, adequate preservation allows for histocompatibility testing
between the donor and a pool of
recipients and the direct cross match
between the donor white cells and
the best matched recipients.
Fourth, function and damage can
be evaluated before the actual transplant, thus eliminating those organs
which have been irreversibly damaged during the agonal period of
the donor. This aspect is still in
the investigational stage, but it appears that the perfusion characteristics are of the greatest importance.
Fifth, adequate preservation is
essential for organs such as the liver
and heart, because preparation of
the recipient is more time-consuming. This problem at the present
time is usually eliminated by preservation in the donor, the so-called
heart-beating cadaver.
Sixth, it makes the transplant an
elective instead of an emergency
operation, which can be of the
greatest importance if the kidney
becomes available during a period
of time when all operating rooms
are filled.
Seventh, if preservation and selection of organs could be perfected, a much larger source of
donor organs would become available. If we are going to be using
the so-called neurological deaths
only, not enough kidneys will be-

come available to treat all patients
in chronic renal failure. However,
if we could use kidneys from other
patients, such as automobile accident victims or other trauma cases
who either enter the emergency
room dead on arrival or die within
the first 20 minutes, the number of
available organs would be tremendously increased.
Finally, it does allow a smaller
staff on the transplant team, since
the donor nephrectomies, as well
as the transplantations, can be done
by one team.
Methods
Perhaps at this point we should
briefly mention the different methods that have been used for preservation of whole organs. They are
hypothermia, hyperbaric oxygen,
isolated perfusion, metabolic inhibitors, and, finally, a combination
of the above methods. When our
studies were initiated, we felt that
perfusion would theoretically be the
best method, as pxygen could be
supplied, and C02 and metabolic
waste products could be removed.
To eliminate the problems of microemboli, we started with an acellular
perfusate such as serum or plasma.
However, we were plagued initially
by the same problems that all other
investigators have had with isolated
perfusion-increasing perfusion
pressure, decreased flow, and tissue
edema. On implantation, even after
short periods of preservation, the
organs did not function ; or, if they
did function, they showed evidence
of some permanent damage.
We then noticed that, if the
plasma were frozen and quickly
171
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thawed, a precipitate developed in
the plasma, producing a completely
opalescent solution. We found that
the most efficient way of removing
this precipitate was by serial filtration through Millipore filters, and
that, by so doing, a clear solution
was obtained. Perfusion with this
cryoprecipitated plasma eliminated
the problems of rising perfusion
pressure and tissue edema. When
fat stains were used on the kidneys
perfused with normal plasma, multiple fat droplets were seen in the
capillaries, the glomeruli and the
tubules. Fat stains of kidneys perfused with cryoprecipitated and filtered plasma did not show these fat
emboli; thus, it became obvious that
the etiology of the rising perfusion
pressure was due to fat emboli obstructing the capillary system.
When blood is used, these emboli
can come from blood cell aggregates; but even if the cellular components are removed, the end stable
lipoproteins denature, and their aggregates are just as destructive.
Furthermore, this process is selfperpetuating. Once decreased capillary flow is produced, it results in
tissue hypoxia, which is shown to
produce cellular swelling, especially
when combined with hypothermia.
The cellular swelling by itself produces increased capillary resistance
and further decreased capillary
flow, and the cycle continues until
death of the cells and the organ
results.
Results

We next performed 24-hour and
72-hour preservation studies in
dogs, and autotransplantation was
combined with immediate contralateral nephrectomy. All animals in
both groups survived. The average
BUN rise in the 24-hour group was
80 mg%, occurring usually on the
third or fourth day, while in the 72hour group the BUN rose to an average of 140, again on the third or
fourth day. However, there was a
subsequent rapid decline in the
BUN, so that the 24-hour groups
172

had normal BUNs by the seventh
or tenth day, while in the 72-hour
group the BUN returned to normal
by the third week. The animals
were then retested after six
months, and conventional as well
as electronmicroscopy studies revealed normal architecture. Paraaminohippuric acid and inulin
clearance studies were within normal limits, and none of the animals
developed hypertension. In order
to be sure that there was no acceleration in the rejection process,
we did several homotransplants
using 24-hour perfused kidneys,
and the animals rejected their kidneys in the normal period of time
ranging from 7 to 21 days.
In August, 1967,. we did our
first human preservation study;
in this, the kidney was preserved
for 17 hours. The patient subsequently developed tubular necrosis
lasting two weeks, after which the
kidney started to open up. His
creatinine clearance went as high
as 40, at which time he had his
first rejection episode. This was partially reversed, but he subsequently
had two more rejection episodes
requiring maintenance on fairly
high doses of steroids. Six months
after transplantation he entered the
hospital with a ruptured gallbladder
secondary to amyloidosis, from
which he later succumbed. Of particular interest is the fact that no
amyloid was found in the transplanted kidney six months after
transplantation.
At that time, our equipment was
not transportable, and we found
that if the kidney was obtained in
one hospital and had to be transferred to the Medical Center before preservation could be started,
the anoxia time was still considerable. The preservation unit
was thus made transportable, so
that it could be moved to the operating room where the donor kidneys were obtained. The perfusion.
circuit, details of which have been
published in several other articles,
basically consists of a pulsatile
pump, a heat exchanger, an organ

chamber, a membrane oxygen.ator,
a cooling system, a pressure recorder and a battery system. For
perfusing human kidneys, we use
fresh frozen AB+ plasma which is
cryoprecipitated immediately before use. The final filter in the Millipore filter system is 0.22µ. and acts
also as a bacterial filter. Immediately before use, several additives, such as phen.olsulfthalein,
magnesium, steroids and antibiotics,
are added to the perfusate. We have
used this method in 42 patients,
and the longest period of preservation has been 36 hours. The kidney
functioned immediately.
Summary

Although it is too early to draw
any definite conclusions from these
results, as a period of two years
is probably necessary to evaluate
cadaver kidney transplantation in
humans, it appears that our wellmatched patients have much fewer
problems than our poorly matched
patients. It is hoped that by preservation methods such as those discussed, improved methods of tissue typing, and better immunosuppressive therapy, we will be able to
raise the survival level of cadaver
kidney transplantations to the level
between 80 and 85% presently being obtained in transplantations using living, related donors.

Isolated Organ Perfusion : Physiology
and Application*
WILLIAM E. GAYLE, JR.

Department of Surgery and Strauss Surgical Research Laboratories,
Medical College of Virginia, Richmond 23219

History
The perfusion of isolated organs
is certainly not a new idea (Table
1). Le Gallois, although probably
not the first to perfuse isolated organs, predicted in 1812 that life
could be maintained in organs by
ex vivo perfusion (Norman, Covelli
and Sise, 1968) .
Elaborate mechanical perfusion
systems were developed by Ludwig
and Schmidt in 1868 and Lindbergh
and Carrel in the early 1900's (Carrel, 1912; Perry et al., 1968).
Our current techniques have added
significantly to knowledge in many
fields, including physiology, transplantation, immunology, toxicology,
pathology and pharmacology. I
will attempt to cover some of the

more interesting and important recent developments in. perfusion and
show its application to understanding fundamental physiology.
Systems
Basically, there are three types
of isolated perfusion systems. An
isolated in vivo system has an intact animal in which a specific organ is isolated by cannulation. The
importance here is that the neural
system remains intact while the
"isolated" organ and its responses
are being studied. An isolated ex
vivo system has an organ removed
from an animal, and that animal
( isologous) or another animal (homologous or heterologous) has its
blood circulated through the organ,

TABLE 1
History of Organ Perfusion*
1812

1828
1849
1858
1866
1869
1875

1913

* Presented at the Fortieth Annual
McGuire Lecture Series, October 31November 1, 1968, Medical College
of Virginia, Richmond.
MCY QUARTERLY 5(4): 173-181, 1969

1931
1935

Le Gallois

Kay
Lobell
Brown-Sequard
de Cyon
Ludwig and Schmidt
Luchsinger
von Fry and Gruber
Brodie, Hamel and
Jacobj
Carrel
Lindbergh
Carrel and Lindbergh

"If one could substitute for the heart a kind

of injection. __ of arterial blood, either
natural, or artificial ... , one would succeed
easily in maintaining alive indefinitely any
part of the body whatsoever."
first artificial circulation to restore muscle
kidney perfusion
brain perfusion
heart and liver perfusion
perfusion apparatus
liver perfusion
pulsatile pump
aeration and perfusion
culture of organs
coil apparatus
thyroid perfusion lasting 18 days

* (Carrel and Lindbergh, 1938.)
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which is usually contained in a box
or bag. In this system, the neural
factors are severed where as, the
hormonal factors remain intact. Finally, a complete isolated in vitro
perfusion system utilizes an artificial pump and various perfusate
mixtures or anticoagulated blood.
Neither hormonal nor neural response mechanisms are intact in
this system, and the circulation is
regulated by the pump and the
intrinsic neural mechanisms.
Problems in Perfusion
With these systems in mind, let
us look at some of the problems
in organ perfusion. In the intact in
vivo system, problems of cell death
are seldom encountered unless the
drugs administered to the organ or
the perfusion apparatus directly
damage the cells. In vitro systems
inevitably result in cell death no
matter how elaborate the system or
how nutritive the perfusate. It is imperative to resolve the etiology of
cell death in ex vivo and in vitro
systems in order to establish better
maintenance of organs and thereby
prolong survival for the purposes
of study and, perhaps more importantly, transplantation.
Whether or not cell or organ
death is due to vasospastic phenomena, lack of endothelial integrity,
or plugging by embolic fatty products is not yet clear. One or several
of these phenomena may be causative, depending upon such factors
as the mechanisms of perfusion, the
choice of perfusate, the oxygenation and the organ. It has been
suggested (Belzer et al., 1968) that
one cause of organ death in some
isolated systems is emboli of lipid
aggregates. According to Belzer,
these emboli could cause tissue
hypoxia with resultant cellular
swelling, anaerobic metabolism,
acidosis and death. The common
denominator in cell and organ
death is hypoxia due to inadequate
perfusion. It has been recently demonstrated (Cohen and Folkman,
1968) that the pathogenesis in174

volved in hypoxic cell death is inadequate perfusion or inadequate
oxygenation. Hypoxemia leads to
anaerobic glycolysis within the cell
and produces an intracellular lactic
acidosis. As a result, there is a
lack of energy because of the
anaerobic metabolism. Without energy the sodium pump mechanism
fails, and water is imbibed into the
cell, producing edema. The lysosomes swell and the resultant release of enzymes caused by acidity,
temperature rise, or decreasing osmotic pressure produces self-destruction of the cell.

How can one, then, detect cellular
death early in the perfusion of isolated organs so that something can
be done? The answer to this
question is far from being simple
depending, as it does upon many
factors. It is dependent upon the
organ under study. If one is studying the kidney, for example, it is
difficult to correlate specific enzyme
changes with cell death. Other factors, including urine output, blood
flow and appearance, do not necessarily correlate with ultimate viability of the organ. A group of investigators (Belzer et al., 1968) have
recently demonstrated that there
may be some correlation between
LDH isozymes and the prediction
of viability of perfused kidneys.
Rising perfusion pressure has also
been shown to correlate with total
renal function in isolated organs

Assessing Viability
For transplantation purposes, it
is imperative that organ viability be
assessed with some degree of assurance prior to reimplantation.
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Fig. 1- The pump regulates arterial flow (A pump) and venous flow (V pump )
separately through the livet. A bubble oxygenator is used with a heat exchanger.
Pressures and flows (AF and VF) are continuously monitored. (Reprinted with
permission from W. E. Gayle, Jr., G. M. Williams and D. M. Hume in Organ
Perfusion and Preservation, Appleton-Century-Crofts, 1968, p. 807.)
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and probably indicates renal death
(Belzer et al., 1968) . The pathologic mechanism is obstruction to
the renal vasculature, and the perfusion pressure rises because of inadequate perfusion of these small
vessels. In an organ which has an
active enzyme system, such as the
liver, there are more readily detectable enzymatic changes which correlate with cell death. The major
question here is : To what degree
enzyme change indicates whether
the liver will or will not survive
and immediately support life after
reimplantation. This is dependent
upon the amount of anoxia it suffers during extirpation, perfusion,
preservation, and reimplantation.
There are many parameters for
studying acute changes of liver
damage, the more common being
the measurement of SGOT (serum
glutamic oxaloacetic transaminase),
SGPT (serum glutamic pyruvic
transaminase), potassium and glucose changes and lactate-pyruvate
ratios.
Regarding the applicability of
isolated organ perfusion to transplantation, one should closely examine the various ways of assaying
viability of different organs prior
to reimplantation. Appearance of
the organ is often helpful in detecting the presence of edema, poor
venous return, or the presence of
inadequate oxygenation, as, with
these conditions, there may be
blotchiness or poor color in general. Excretory output can also be
measured, although this does not
necessarily correlate with function.
Chemical assays, including those
of enzyme changes in the kidney,
liver, and heart, are important, as
changes in perfusate pH, temperature, oxygen concentration, and
carbon dioxide content. Pressure
changes in the chambers of the
heart as a measure of contractility
may be beneficial in assaying the
viability of the heart. Tetrazolium
bromide dye is a rapid method for
attempting to assay cardiac viability (Maginn and Hadjimichalis,
1968) . Jn studies by Idezuki et al.

( 1968) , pancreatic viability was
determined by giving an isolated
pancreatic graft a glucose stimulation test which, if the graft was
viable, brought about the immediate production of insulin. Even
with minimal output of insulin
after 48 hours of perfusion, this
test indicated a viable graft that
functioned on reimplantation .
As mentioned previously, in an
ex vitro perfusion system, the excretory functions of organs, such
as the kidney and liver, were not
totally reliable as adequate assays
of viability. The kidney can put
out large amounts of urine which is
isosmolar with the perfusate and
represents simply an ultrafiltrate of
a dying kidney. Similarly, the liver
can put out bilious-appearing material which, if assayed, proves to
be a poor quality of true bile and
probably represents an ultrafiltrate
type of material. Flow rates through
organs depend upon several . factors: whether the perfusion is normothermic or hypothermic ; the
method of perfusion; the type of
pump used; whether or not the
pressure is constant; and the
amount of vascular resistance
within the organ system. One elaborate system (Norman et al., 1967)
provides the ability to monitor the
intake and output via a computertype setup and, thereby balance
and control the precise amount of
flow. In our laboratories we utilize a pressure-sensitive EdwardsBoshert pump, which detects resistance and, as the resistance increases, automatically and proportionately diminishes the flow (Fig.
1). Diminishing flow rate provides
us with immediate evidence of intravascular resistance secondary to
vasospasm, occlusive disease, or
other problems which raise resistance and diminish inflow. We feel
that this is a highly physiologic system in that, essentially, it allows the
organ to control its own flow by intrinsic autoregulation.
t Edwards-Bosher Coronary Perfusion Unit. J. F. Edwards Company,
Harrisonburg, Virginia.

Clearance studies, such as excretion of dyes in the isolated kidney
preparation or excretion of bromsulphalein or ammonia in the
isolated liver preparation, are also
utilized for detection of viability.
These are probably somewhat more
reliable than the simple measurement of excretory rate alone, because excretion of the dye demands
cellular function.
Another method of assaying viability is pathology, including light
and electron microscopy. Because
it takes time for the preparation
of sections, these methods prevent
obtaining conclusive evidence of
viability immediately prior to implantation.
The sine qua non of assaying
viability, of course, is normal function after reimplantation. This is
the only reliable indicator of adequate viability of the organ. The
obvious problem here is that, where
human transplantation is concerned, this implies surgical manipulation of the patient (recipient)
in order to detect viability of the
organ involved . The immediate
need, of course, is for some quick,
reliable, and accessible method of
assaying viability of isolated organs
being perfused for transplantation .
Various aspects of such a method,
including chemical changes, excretory clearance functions and vital
dye studies, are presently being
pursued with the greatest interest
at the present time.
Mechanics of Perfusion
Returning to more basic physiology, let us consider some of the
actual mechanics of perfusion of
isolated organs . There are many
variables in an isolated system. The
first of these is temperature. Perfusion at normothermia (37 C) ,
at room temperature (25 C), or at
considerable hypothermia ( 4-10 C),
for the purposes of prolonged preservation, depends upon the desires
of the investigator. Almost all physiologic, pharmacologic, toxicologic,
and immunologic studies are per175
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formed at body temperature, but,
for the purposes of studying preservation techniques, hypothermia
is usually utilized, since the metabolic rate is markedly diminished.
However, it produces problems,
such as associated vasospasm and
sludging of blood when cellular
products are present, inactivation
of heparin at low temperatures,
and inactivation of certain drugs.
Another basic consideration in
the mechanics of perfusion is the
presence or absence of hyperbaria.
Belzer (Belzer, Ashby and Dunphy, 1967) has adequately demonstrated that hyperbaria is not necessary for the preservation of
kidneys for a period of up to 24
and, perhaps, even 72 hours with
the use of hypothermia and a plasma
solution. Other investigators (Brettschneider et al., 1968) have demonstrated that, for their purposes,
hyperbaria is necessary to maintain viability during preservation of
human and canine livers. Recently
it has been demonstrated that hyperbaria sufficiently suppresses cellular swelling in the liver for a
period of 24 hours (Huntley et al.,
1968). However, after 24 hours the
enzymes are markedly altered, and
the liver is not sufficiently functional to support life. The perfused
liver gains weight at a rapid rate
after the first 24 hours, whether or
not it is in a hyperbaric atmosphere. Hyperbaria may be necessary for prolonged preservation of
the pancreas and, perhaps, the
heart and the lung. However, there
are certain inherent disadvantages
to hyperbaria : 1) Compression and
decompression take several extra
hours; 2) There is potential danger
of an accident with the high pressure system; and 3) Excess oxygen
will damage in vitro tissue culture
cells, although it is difficult to assess its effect on whole organs.
It has been shown that hyperbaria
(using nitrogen or helium) will accomplish effects similar to those
accomplished by hyperbaric oxygen, and it is speculated that pressure alone may be the important
176

factor (Lyons, Dietzman and Lillehei, 1966).
A third consideration in perfusion mechanics is the type of pump
and oxygenator utilized . As previously mentioned, we use the Edwards-Bosher pump, because we
think it is physiologically sound.
Belzer and Folkman both utilize
different types of pumps and obtain very satisfactory results. These
pumps are basically pulsatile. It
has been demonstrated by work in
our own laboratory (Robertshaw
and Gayle, unpublished data) and
by others (Tait and Eisenman,
1966) that pulsatile perfusion allows lymphatics to empty during
the diastolic phase and, therefore,
diminishes edema formed in the
parenchyma and around the capsule
of the organs. The type of oxygenator is also important. It has recently
been demonstrated that disc oxygenators, which have a large surface contact with the actual perfusate, have increased screen filtration pressure (Ashmore, Svitek
and Ambrose, 1968) and as previously mentioned (Belzer et al.,
1968), may cause problems with
embolization of fatty materials.
Membrane oxygenators have been
utilized for bypass over periods of
12 to 24 hours and have a very
minimal increase in screen filtration pressure. We have recently
switched to a membrane oxygenator
for our preservation system but
have, however, been able to successfully preserve some kidneys for
24 hours with a disc oxygenator.

A fourth area of importance in
perfusion is the choice of perf usate.
Again, there is much controversy
as to the exact type of perfusate to
use. This is dependent upon the
type of study desired by the individual investigator. If the system
is to be as physiologic as possible,
a whole blood or dilute whole blood
solution is utilized. Problems involved, however, are sludging and
outflow block-especially in the
liver-if a whole blood solution
is utilized. Regardless of the perfusate used, perfusion of the lungs,
without ventilation, is problematical for maintenance of viability
(Stevens et al., 1968). In preservation (Table 2), dilute whole
blood solutions have worked satisfactorily with lung and liver. With
kidney preservation, the use of a
plasma solution has been shown by
Belzer to be the most satisfactory
(Belzer et al., 1967) . The use of
crystalloid solutions has been shown
by some investigators to be nearly
as effective as that of plasma. However, one does run into the problem
of edema after occurring long
preservation. Depending upon the
study, many additives have been
utilized in perfusates, including
magnesium, steroids, antibotics,
adenosine (Stewart and Wilbrandt,
1968) , chlorpromazine, buffering
agents, glucose and insulin.
The question of inclusion of cells
in the perfusate has been a very
controversial one. Up until recently
it was thought that platelets might
be harmful; however, it appears that

TABLE 2
Perfusates for Preservation
Kidney-

homologous undiluted ACD plasma, room air, pulsatile perfusion,
moderate hypothermia

Liver-

dilute heparinized whole blood, hyperbaric oxygen, hypothermia

Lung-

ventilation, ? perfusion (dextran-ACD-blood), ? hyperbaria (2A)

Pancreas- non-perfusion relatively successful to 22 hours
Thymus- Eagle's MEM, fetal calf serum
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Fig. 2- Isoproterenol added to an isolated perfused liver with a falling venous flow produced immediate increase in flow.
Folkman has renewed the desire to
have platelets present to insure phys·
iologic preservation of the endothelium (Gimbrone et al., 1969). He
and his colleagues have demonstrated that the platelet, which is
thought by some to contribute to
problems in isolated organ perfusion, may be an important factor
in maintaining the integrity of the
vascular endothelium. They have
recently demonstrated this by perfusing dog thyroid glands with
platelet-rich plasma and comparing
them to thyroids perfused simultaneously with platelet-poor plasma
under identical conditions. The
endothelium seems to be maintained with adequate function after
re-anastomosis in organs perfused
with platelet-rich plasma for 24
hours. Platelet-poor perfused thyroids, however, after a period of
three to four hours, swell and have
petechial and purpuric hemorrhages

in their subcapsular area on reimplantation. This is perhaps the newest and most exciting concept in
organ perfusion and preservation
and goes against the theory of many
workers in the past (Humphries,
1967).
One final perfusate which has
been used for maintenance of
perfusion in isolated organs (Paton
et al., 1968) and in the total rat
model (Geyer, Monroe and Taylor,
1968) is the fluorocarbon perfusate
(Pluronic F-68) . Geyer et al. have
described a highly intriguing application in which rats were completely exchanged with a fluorocarbon-serum emulsion without cells,
maintained at 100% oxygen atmosphere, and kept alive for six to
eight hours. If washed erythrocytes
were added to fluorocarbon emulsion, the animal survived indefinitely after being perfused for up to
140 minutes.

MCV Data
At this point I would like to relate some of the work recently
done in our laboratory to the aspects of organ perfusion and
transplantation. D octor William
Harlan (O'Brien, H arlan and White,
unpublished data) has recently
shown that palmitic acid, which is
probably the major source of energy for the renal cortex, is markedly diminished in canine renal allografts as compared to isografts
and normals. It is hoped that we
can apply this work and its implications to the study of rejection.
Other studies relevant to transplantation are being performed
by one of our medical students, Mr.
Harold Levinson, who is using an
isolated rat perfusion system modeled after that of Doctor Judah
Folkman to study in :vitro aspects
of rejection. Utilizing PA and Lewis
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rat strains, lymphocytes can be obtained from the thoracic duct of
one rat strain. Either a culture
medium which is isologous to one
rat strain or a medium, such as
Medium 199, which is indifferent
to both strains, is used to suspend
the cells. Thoracic duct lymphocytes, tagged with chromium
153, are utilized to perfuse syngeneic and allogeneic rat strains.
Counts of the venous effluent as
well as counts of the total kidney
are monitored after a standard perfusion time. These data appear to
demonstrate that the allogeneic
kidney took up more sensitized lymphocytes than did the syngeneic
kidney. Preliminary data on the
venous effluents, however, have not
proved consistent in their results.
Utilizing tagged red cells to reveal
whether the kidneys were being
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adequately perfused, Levinson demonstrated that the kidneys are not
always being perfused equally in
the cortical and medullary areas.
Doctor Gilbert Robertshaw has
published an excellent report on the
presence of serum antibody which
is not cell-bound (Robertshaw et
al., 1967). One of a set of unrelated mongrel dogs was subjected to
a first-set transplant that used a
kidney which was allowed to reject
and was then removed. After a
short rest period, a second-set graft
was performed utilizing either skin
or spleen. Skin grafts were subsequently performed until a "whitegraft" reaction was obtained, implying hyperacute rejection. The
kidneys of the original donor were
placed in a perfusion circuit, and
the serum of the hypersensitized

recipient dog was added to the perfusion system after a baseline was
obtained. It was immediately demonstrated that the donor kidney
swelled, and the urine output diminished rapidly. A recipient kidney was used as a control. Upon
analyzing these data, Robertshaw
found that there was a decrease in
renal arterial flow, oxygen uptake
across the kidney, urine output and
urine osmolality in the donor kidney. Pathologic examination revealed proteinuria and increased
edema.
In a more recent study (Robertshaw et al., unpublished data) the
donor kidney, after being perfused,
was replaced in the donor animal
and allowed to perfuse for 30 minutes to 2 hours. Urine output remained low. On pathologic exami-

nation, polymorphonuclear leukocytes were shown to adhere to the
endothelial lining of the kidneys,
demonstrating continuance of the
hyperacute rejection phenomenon.
Work done with isolated liver perfusions in our laboratory has demonstrated that there are probably
beta-adrenergic receptors within
the vasculature of the liver which
are affected by isoproterenol (Figs.
2, 3) and tend to cause vasodilatation of the postsinusoidal sphincter
mechanism (Gayle, Williams and
Hume, 1968). This causes relaxation and allows increased flow,
especially if the system has been
previously subjected to vasospasticity with either norepinephrine or
epinephrine, both of which produce
marked vasoconstriction and diminution of flow through the liver
179
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(Figs. 4, 5). With the administration of isoproterenol, increased
flow is more marked in the venous
phase than in the arterial phase
(Figs. 6, 7). Lymphatic output, as
measured by direct cannulation of
perihilar lymphatics, is increased
with the administration of vasoconstrictive agents. With the relaxation
of the sphincter accomplished by
isoproterenol, the lymphatic output
diminishes. It is our feeling that if
post-hepatic transplantation support
to the cardiovascular system were
needed, isoproterenol would probably be the drug to choose, since
vasopressor agents, such as norepinephrine or epinephrine, would
harm the liver by causing vasospasm. However, not enough work
has been done with human livers to
definitely corroborate this in the
human system. We are also, at present, working on effects of certain
anesthetic agents on hepatic flows
and pathologic changes.
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Fig. 6-Mean arterial flow was slightly but consistently increased only by
isoproterenol (Drug 1) when the mean changes in flow were recorded for 15
dog livers after injection. Drug 2 is epinephrine and Drug 3 is norepinephrine.
(Reprinted with permission from W. E. Gayle, Jr., G. M. Williams and D. M.
Hume in Organ Perfusion and Preservation, Appleton-Century-Crofts, 1968,
p. 811.)

Conclusions
Isolated organ perfusion provides
us with an excellent tool for investigating the physiology and the
function of a variety of individual
organs. It enables us to explore
these organs, their pbarmacologic
reactions, their ability to withstand
various stresses, their pathology
after stress and their suitability for
preservation and transplantation.
Isolated perfusion has allowed us
to better understand hemodynamics, effects of various perfusates,
and toxicity of drugs on individual
organs. We h ave recently been enlightened about the vital role of
platelets and endothelial integrity.
We now have a model for assessing
individual hormonal systems and
qualitative and quantitative endocrine and exocrine functions. Organ
perfusion has provided us with
a method for preservation and a
means for studying organ viability
prior to transplantation. We now
have an invaluable isolated system
in which we can study certain
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aspects of immunology, including
the rejection mechanism, sensitization, and the evaluation of serum
and cell-bound phenomena. Our
immediate goals include detection
of cell or organ death prior to reimplantation by some rapid and
accurate method and prolongation
of preservation time for in vitro organ systems.
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Introduction

At the present time successful
clinical organ transplantation depends on chronic administration of
immunosuppressive agents to prevent the persistent tendency of the
recipient to reject the graft. Chronic
immunosuppression- although often successful in maintaining graft
function and viability-is frequently
associated with numerous and often
fatal complications. These associated problems include: 1) inherent
tox1c1ty of immunosuppressive
drugs per se, e.g., lmuran (hepatitis), steroids (osteoporosis, gastrointestinal bleeding, etc.) , Cytoxan
and actinomycin C ( thrombocytopenia, leukopenia) ; 2) occurrence
and persistence of low-grade rejection in the graft, e.g., endarteritis
in renal and cardiac allografts,
while function is maintained; 3) occurrence of severe and bizarre infections, usually those associated
with cellular immunity (particularly
of the viral, protozoan and fungal
varieties); and, finally, 4) spontaneous appearance of malignancy,
presumably due to the abolition of
the immunological surveillance
mechanism which is probably operative in preventing the de nova
appearance of malignancy in most
normal human beings. For these
reasons specific immunological tolerance remains the ultimate and
eventual solution to the widespread

* Presented at the Fortieth Annual
McGuire Lecture Series, October 31November 1, 1968, Medical College
of Virginia, Richmond.
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application of clinical organ transplantation.
Immunological Tolerance

The phenomenon of actively acquired immunological tolerance was
discovered during studies of tissue
transplantation. This term was used
to describe a specific state of unresponsiveness to an antigen or antigens in adult life as a consequence of exposure to antigen in
utero or in the neonatal period. In
a study of the immunogenetic consequences of vascular anastomoses
between cattle twins in utero, Owen
( 1945) showed that most cattle
twins at birth are erythrocyte chimeras as they possess erythrocytes of their own genotype as well
as those of the opposite twin. This
chimeric state was shown to persist
beyond the life span of the erythrocyte, suggesting that erythropoietic cells (stem cells) were exchanged in fetal life and continued
to produce erythrocytes of characteristic serological type throughout adult life.
The wide significance of Owen's
observation was emphasized by
Burnet and Fenner (1948) in a
general theory of the immune response which predicted the phenomenon of tolerance. To explain
the failure of adult animals to react immunologically to their own
tissues, these authors suggested that
the body cells possess some type of
self-marker component, and that
the capacity to recognize this self
pattern develops during embryonic
MCV QUARTERLY 5(4): 182-189, 1969
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or early postnatal life. They predicted that exposure to an antigen
in embryonic life would cause that
antigen to be recognized as self
in later life, and, consequently, no
immune response would be made to
it.
In future studies, it became apparent that erythrocyte chimerism
was not the only manifestation of
tolerance in dizygotic cattle twins
which appeared after mixture of
placental circulations. Dizygotic
cattle twins were shown to accept
skin grafts from each other, and
this mutual tolerance was specific
since skin grafts transplanted from
third parties were quickly rejected
(Anderson et al., 1951). These observations in nature set the stage
for the production of actively acquired tolerance by Medawar and
colleagues in the laboratory. These
investigators injected mouse embryos of the CBA strain in utero
through the anterior abdominal
wall with a suspension of living
spleen cell lymphocytes of the
A strain (Billingham, Brent and
Medawar, 1953). The CBA recipients, regularly accepted A-strain
skin grafts when grafted in adult
life. This tolerance of A-strain
grafts was specific, since CBA mice
tolerant of A-strain tissues easily
rejected allografts from the unrelated AU strain. At the same time,
Hasek reproduced Owen's observations in chickens by the ingenious
method of making a deliberate
synchorial parabiosis of embryos
via the chorioallantoic membrane
(Hasek, 1953). At hatching, the
parabiots were separated and were
found to be tolerant not only of
each other's red cells, but skin allografts. Subsequently, it was found
that in utero injection was unnecessary, and that intravenous injection
during the early neonatal period
also produced tolerance. In these
experiments tolerance could be
abolished by the injection of tolerant animals with lymphoid cells
from normal adult members of the
same syngeneic strain. Furthermore, careful testing showed that

the tolerant mice were, in fact,
chimeras insofar as their lymphoid
cell populations were concerned
(Billingham, 1958). Tolerance induced in the neonatal period was
frequently permanent. This was in
sharp contrast to the transient nature of the tolerance to chemical
antigens observed by a number of
other investigators when non-living,
non-replicating antigens, such as
proteins, were injected into neonatal
animals for varying periods from
birth to adulthood.
The demonstration by Smith and
Bridges ( 1958) and Mitchison
(1959) of the necessity of repeated
injections of non-replicating antigens to maintain tolerance toward
these antigens, coupled with the observation of chimerism in tolerant
mice in Medawar's experiment, emphasized the concept that persistence of antigen was necessary for
the maintenance of tolerance.
Another important aspect of tolerance induction involves the genetic relationship between the donor
and the immature host. It was
found that the more distant the
histocompatibility relationships between donor and host, the more
difficult it was to induce tolerance.
When strong histocompatibility barriers existed, large innoculums of
cells were.required, the intravenous
route was obligatory, and the
tolerance-responsive period extended only to a short time after
birth. On the other hand, when the
genetic and, therefore, antigenic disparity between donor and host was
relatively weak, such stringent requirements disappeared. In fact,
when mice of very weak histocompatibility differences were used, the
tolerance-responsive period extended even into adulthood (Shapiro et al., 1961).
Graft-Versus-Host Reaction

Just as the phenomenon of actively acquired tolerance was discovered in tissue transplantation
research, so also was the graf!-versus-host reaction (hereafter, GVH

reaction) basically an outcome of
research in immunological tolerance. Simonsen (1957) found that
adult splenic cells, when injected
into newborn or embryo chickens
and mice, produced a disease that
could only be interpreted as an outcome of an immunological response
by these grafted cells against the
host. Simultaneously, Billingham
and Brent (1957), in their attempts
to induce tolerance in newborn
mice, found that, in certain strain
combinations, all injected mice died
from a peculiar wasting disease.
They concluded that a GVH reaction was the likely explanation of
this pathological condition which
they named runt disease. GVH reactions result when a recipient of
a graft comprised of immunologically competent cells is incapable of
rejecting the cellular ·graft. This situation typically arises in very young
individuals (embryos and newborn
recipients). It also occurs in adults
when a graft from a homozygous
donor, i.e., genetically AA, is given
to a host that is an Fi hybrid between the donor strain and a dissimilar strain, i.e., genetically AB.
A graft A transplanted to an AB
host represents a situation in which
the hybrid cannot reject the graft
by immunological means even
though the host may be entirely
competent immunologically. This is
true because the graft does not
possess any antigens that are foreign to the host. The graft, however, can react against the host,
since the latter contains foreign
antigens derived from the dissimilar
parent of the hybrid.
The mouse is the classic animal
for the production of GVH reactions and runt disease. In severe reactions, mice grow normally
for about a week, but thereafter
growth ceases, and there is subsequent weight loss, associated with
diarrhea, alopecia, dermatitis and
eventual death . This pathological
condition has been demonstrated
in numerous other species. It is of
great clinical significance that human recipients of bone marrow
183
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transplants, especially after immunosuppressive treatment with whole
body irradiation or cytotoxic drugs,
have shown all the symptoms of
classical GVH reactions similar to
those observed in lower species. The
most important parameters which
determine severity of GVH reactions are: 1) the immune competence of the cells utilized; 2) the
dose of the cellular innoculum; and
3) the degree of histocompatibility
difference between the donor and
the recipient. The pathological
symptoms and the mortality rate
increase as these parameters increase.
Immunological Tolerance and
Antilymphocyte Serum

Induction of specific immunological tolerance to either tissue allografts or non-replicating, chemically defined antigens, such as
proteins, is by no means limited to
neonatal or immunologically incompetent young animals. Tolerance can be induced in adult, immunologically competent animals
under a number of special circumstances. For example, it may be
induced by the injection of massive
amounts of antigen (so-called immunological paralysis or antigen
overloading) or by the injection of
antigen during certain times of immunosuppression or lymphocyte
depletion. Immunological depression in adult animals to abet the
induction of tolerance has been
achieved in a number of different
ways, i.e., irradiation, cytotoxic
drugs, steroids or a combination
of these (Russell and Monaco,
1965) . In our laboratory, heterologous antilymphocyte serum (ALS)
has been used as an immunosuppressive agent to facilitate the induction of tolerance to tissue allografts in adult animals. It is the
purpose of this report to review
our experiments in this particular
area.
Heterologous ALS is an extraordinary immunosuppressive agent.
Mice treated with this reagent show
184

a dramatic inability to reject tissue
allografts and xenografts (Gray et
al., 1966; Monaco et al., 1966).
Recent evidence indicates that ALS
acts mainly on peripheral circulating lymphocytes (Taub and Lance,
1968) . The mechanism of action
of ALS continues to be uncertain,
but evidence suggests (Monaco,
Wood and Russell, 1965a) that its
immunosuppressive property depends on its effects on thymusdependent, immunologically competent lymphocytes. ALS frequently
induces peripheral lymphopenia
and tissue lymphocyte depletion,
and the treated animals are nonspecificall y immunosuppressed.
Some serums, equally immunosuppressive, do not necessarily produce
a dramatic and sustained lymphopenia. It appears, therefore, that for
ALS to be immunosuppressive, it
must act on a select group of peripheral lymphocytes which is probably quite small in number, and its
effectiveness is not dependent on
the lymphopenia per se, but rather
on the depletion or destruction of a
certain population of immunocompetent, thymus-dependent cells. Recent work suggests that ALS is
highly effective in depressing cellular-type immunities, as typified by
reaction of tissue allografts, whereas the humoral antibody response
to certain antigens, especially bacterial ones, is much less affected.
The depression of immune capability following treatment with ALS
may be due to the decreased number of mature lymphocytes and/ or
to the immune incompetence of remaining lymphocytes. From our
experiments it appears that the lymphoid cells exposed to ALS in vivo
an din vitro do not live on and replicate (Van der Werf et al., 1968),
since ,they do not induce GVH reactions in susceptible recipients or
tolerance and chimerism in neonatally injected histoincompatible
mice. This supports the concept that
the cells remaining in lymph nodes
after rabbit anti-mouse lymphocyte
serum (RAMLS) treatment are immunologically incompetent. These

remammg cells (or their descendents) eventually become immunologically competent, perhaps under
the influence of the thymus or a
thymic product.
Experiments have been done in
mice and rats to determine whether
or not tolerance is a property associated with the thymus or thymusderived cells. Galton, Reed and Holt
(1964) showed that allograft tolerance occurs with the achievement
of thymic chimerism. This suggested that the presence of allogeneic cells within the thymus
is essential for the induction
and maintenance of a tolerant state
and that the target cell for tolerance induction must be the lymphoid precursor cell within the
thymus. The presence of the antigen within the thymus and the existence of tolerance may, however,
be coincidental, as has been suggested by Miller and Osoba ( 1967).
Other investigators (Follett, Battisto and Bloom, 1966) have shown
that the lymphoid system in adultthymectomized animals can be
rendered specifically tolerant to defined antigens. Thus, the presence of the thymus is not necessary
for tolerance induction. This does
not exclude the lymphoid precursor
cells as the target cells for tolerance induction. These may be present in the thymus-dependent areas
of lymphoid organs (Holborrow,
1968) and be influenced by a thymic humoral factor (Hardy et al.,
1968). The breakdown of tolerance
occurs when immunologically competent cells are recruited from precursors which have not been exposed to the tolerance-inducing antigen. This recruitment appears to
be dependent on the thymus or on
a thymic humoral factor. Claman
and Talmage ( 1963) showed that,
in mice previously rendered tolerant to horse serum albumin, adult
thymectomy delayed the spontaneous escape from tolerance. Argyris
( 1965) showed that the transplantation of C3H/ He thymus tissue
accelerated the breakdown of tolerance in C3H/ He mice tolerant
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the abolishment of a tolerant state,
presumably by its influence on the
development and the recruitment of
immunologically competent cells.
Although ALS is highly effective
in depressing cellular type immunities-as typified by rejection of tissue allografts-while preserving
relatively intact the humoral anti-

to CBA skin grafts. Goldstein et
al. have recently shown that tolerance to A l Jax skin in neonatally
thymectomized CBA mice can be
abolished by a thymic humoral factor (unpublished data). It appears,
therefore, that the thymus or a thymic humoral factor plays an important role in the induction and
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Russell, 1966.)

body responses to certain bacterial
antigens, it must be emphasized that
ALS-induced suppression of tissue
graft rejection is still nonspecific.
Thus, third-party allografts placed
on mice treated with ALS while an
earlier test allograft is alive are rejected at the same time as the test
allografts (Monaco et al., 1966).
Furthermore, adult thymectomy
and ALS treatment produce a prolonged period of nonspecific immune incompetence in the capacity
to express cellular type immunities. Adult-thymectomized, ALStreated mice frequently bear healthy
allografts for over 100 days. Thirdparty grafts applied at that time
also frequently show prolonged
survival. This profound immune incompetence induced by adult thymectomy and ALS seemed analogous to the unresponsiveness seen
in neonatally thymectomized mice.
Because of this similarity, we felt
it might be possible to induce tolerance in adult animals treated in
this manner.
In the initial experiments (Monaco, Wood and Russell, 1966)
adult-thymectomized and normal
A l Jax mice were treated with ALS
and infused with C3H/ He X A/ Jax
Fi hybrid cells intravenously. Fi hybrid cells were used to avoid a GVH
reaction (Fig. 1). C3H/He skin allografts in adult-thymectomized,
ALS-treated, cell-infused mice
showed a markedly prolonged survival , as compared to a dultthymectomized animals receiving
ALS but no cell infusion. Furthermore, thymectomized, ALS-treated,
cell-infused mice rejected thirdparty C57BL/ 6 J skin in a normal
fashion while retaining their first
and, even, second C3H/ He skin
allografts (Fig. 2). This emphasized
the fact that they were specifically
tolerant to C3H/ He tissues. These
tolerant mice were found to be lymphoid cell chimeras, · containing
lymphocytes of both A/ Jax and
C3H/He genotypes. The tolerance
was abolished by injection of normal (syngeneic) A/ Jax lymphocytes, a finding similar to that noted
185
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by Medawar and colleagues in their
tolerance experiments in neonatal
animals. This acquired state of
tolerance associated with a state of
lymphoid cell chimerism was seen
in all the thymectomized mice
which received both ALS and a
cell infusion.
Since hybrid donor lymphoid
cells would never be available in
clinical situations, attempts were
made to reproduce the above experiment using non-hybrid (homozygous) allogeneic lymphoid ceHs.
Severe GVH reactions resulted
when high doses (300 x 10 6 ) of
cells were used. To avoid the GVH
reaction, we used allogeneic histocompatibility antigens in a cell-free
form from the supernatant of
mechanically disrupted spleen cells

(Monaco, Wood and Russell,
1965b) of the skin graft donor.
The addition of this cell-free antigen (CPA) to a course of ALS increased the prolongation of skin allografts slightly over that achieved
with ALS alone. The addition of
CPA to a course of ALS in adultthymectomized mice almost doubled skin allograft survival as compared to that in ALS-treated
thymectomized mice (Abbott,
Monaco and Russell, 1969). Of
major importance was the finding
that third-party grafts were rejected
relatively normally in the thymectomized animals receiving ALS and
CF A, and, therefore, the prolonged
survival of the original allograft
was a form of specific acquired tolerance in the adult.

The tolerance induced with CPA
in such lymphocyte-depleted animals may be long lasting but is not
permanent. Furthermore, the number of animals in any group showing a great degree of tolerance is
less than when replicating lymphoid
cells are used as the donor antigen.
Presumably this results from a regeneration or increase in the number of immunologically competent
cells which can, again, react to the
foreign antigen. Since these cells
are probably thymus-dependent, as
we indicated earlier in this article,
one may justifiably question the
reappearance of immunocompetent
cells in an ALS-treated thymectomized mouse. It is probable that a
small number of immunologically
competent cells can regenerate from

Fig. 2- A. An adult-thymectomized A/ Jax mouse which received ALS for seven days followed by 300 x lQG C3H/ He lymphoid cells, as in Figure 1. The mouse bears a C3H/ He graft in perfect condition for 100 days.
B. The same mouse bearing the same first C3H/ He graft as well as a second C3H/ He graft on day 150.

C. A similar adult-thymectomized, ALS-treated, cell-infused mouse bearing a perfect C3H/ He graft over 100 days but
simultaneously rejecting a third-party C57Bl / 6J skin allograft-i.e., indicating specific tolerance.
D. The mouse visualized in B after infusion with normal syngeneic A/Jax lymphoid cells, showing rejection of previously well-tolerated C3H/ He grafts-Le., the abolition of specific tolerance.
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the bone marrow in the absence of
the thymus. Another possibility is
that residual stem cells in the peripheral lymphoid system (lymph
nodes, Peyer's patches, etc.) may
differentiate to immunologically
competent cells under the influence
of a thymic humoral factor which
persists in such tissues after thymectomy. It may be possible to
circumvent this regeneration by the
addition of small doses of immunosuppressive agents (perhaps in
association with specific antigen) to
prevent the regeneration of new
immunocompetent cells. Apparently, when a chimeric state is
established, regeneration of competent cells and loss of the tolerant
state is delayed or prevented by
persisting donor antigen in the
form of chimeric lymphoid cells.
Until recently we were unable
to induce any form of specific tolerance in the non-thymectomized,
ALS-treated adult mice. On the
contrary, we found that such animals were sensitized after infusion
with allogeneic F1 hybrid lymphoid
cells. These seemingly incompatible
results may be explained by Mitchison's ( 1965) elegant demonstration
that the antigen dose frequently
determines whether tolerance or
sensitization results from antigen
introduction. This investigator
showed that tolerance to bovine
serum albumin in mice resulted
when the protein was administered
in two dose zones, i.e., in high and
low ranges. Doses in other ranges
either produced sensitization or no
effect. The concept of high zone and
low zone tolerance was thus introduced. We tested the effects of various doses (0.01, 0.1, 1.0, 10 and
100 X 10 6 ) of homozygous allogeneic C3HjHe lymphoid cells in
five groups of ALS-pretreated (nonthymectomized) A/ Jax mice. Controls received ALS but no cells.
Figure 3 shows the survival curves
of the test allografts in the various
groups. C3HjHe skin allografts survived longest in AjJ ax mice which
received 10 x 10 6 cells, thus indicating a potentiation of ALS immuno-
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Fig. 3-Survival curves of C3H/ He skin allografts on ALS-treated A/ Jax mice
infused with various doses of C3H/ He allogeneic, non-F1 hybrid lymphoid cells.
(Monaco, in press, 1969.)
suppression by cell infusion, i.e.,
partial tolerance. The grafts in the
groups receiving 0.1 X 10 6 or 100
X 10 6 had a shorter survival time
than the ALS controls, indicating
a partial sensitization by this dose
of cell infusion. Mice receiving .01
x 10 6 or 1 x 10 6 cells rejected
their grafts at the same time as the
controls treated with ALS alone,
showing that there was no effect of
doses of cells in these ranges. These
observations in ALS-treated mice
receiving cell infusions are analogous to those of Mitchison on various protein antigens in which the
resulting reactions of sensitization
and/ or tolerance are probably dependent on the dose of antigen
utilized. Of importance in these
experiments, from the point of view
of potential clinical application, was
the observation that in these lower

dose ranges where partial tolerance
resulted, there was little if any observed GVH reaction.
Lance and Medawar (1969), in
a similar experiment, have emphasized the effect of the timing of
injections of cells on the probability
of their potentiating or sensitizing
the recipient of the graft. Furthermore, these investigators demonstrated that GVH reactions can be
avoided by using cells with decreased immune competence, i.e.,
thymocytes, bone marrow cells, and
cells from ALS-treated donors.
That this phenomenon of acquired partial tolerance induced
with donor antigen is not peculiar
to skin allografts in mice is well
established. Organ allografts appear to be less antigenic than skin
allografts; hence, it will probably
·be easier to develop a tolerant state
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to an organ allograft than to a
skin allograft. We must further remember that organs are attached by
direct vascular anastomosis and
that the antigen is chronically released. This may be important in
maintaining a tolerant state. Thus,
a permanent state of chimerism
might not be necessary to achieve
a permanent state of tolerance.
Seifert et al. (1966) obtained significant improvement in renal allografts by pretreating dogs with
subcellular (cell-free) antigen and
6-mercaptopurine and a dding
methylprednisolone after transplantation. Dagher et al. ( 1967)
used a two-week pretreatment
course with soluble cytoplasmic antigen from viable donor spleen cells
and demonstrated a prolonged renal
allograft survival in dogs when
minimal doses of azathioprine and
methylprednisolone were given after
renal transplantation. These studies
of whole organ allograft survival
suggest that the prolongation was
augumented by the donor antigen.
The use of specific donor antigen
appears promising as an adjunct
in immunosuppressive therapy of
whole organ allografts.
Conclusion
Our interest in the problem of
tolerance induction is directly concerned with clinical organ transplantation. ALS is highly effective
in depressing cellular immunities.
Since at least initial allograft rejection is predominantly a cellular
phenomenon, one would expect
ALS to be highly effective clinically.
Our initial observations in this regard support this concept. However,
non-specific depression of cellular
immunity may also lead to an increased number of viral, fungal,
and protozoan infections. Experiments, such as those presented,
strongly suggest that a specific state
of tolerance to organ grafts in man
should be attainable with the aid of
ALS followed by introduction of
appropriate antigen. A number of
avenues are open to increase the
likelihood of success for clinical in188

duction of tolerance. Improved
methods of histocompatibility typing will aid in tolerance induction,
since tolerance is more easily established when histocompatibility differences are minimized. Much effort
is being expended in isolation of human cell-free histocompatibility antigens in a soluble form (Kahan and
Reisfeld, 1969). Experimental evidence so far suggests that soluble
antigens are less immunogenic and
more tolerogenic. Development of
optimal (non-sensitizing, tolerogenic) antigenic dose schedules-to
be administered after immunosuppression has been achieved-should
facilitate clinical tolerance induction. If antigens are utilized in a
cellular form-as is our tendency at
present-then replicating lymphoid
cells from ALS-treated donors, replicating non-immunologically competent cells ( thymocytes, bone
marrow cells), or nonreplicating
parenchymal cells of appropriate
organs (liver, kidney, etc.) might,
theoretically, be utilized. It is apparent that organ transplantation
cannot be fully applied until the
problem of specific allograft tolerance is solved. A practical solution to the problem may be closer
at hand than we realize.
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Introduction
The problem of homograft rejection in man remains unsolved. Any
organ transplanted from one individual to another (except in the
case of identical twins) will be rejected, unless the rejection process
can be abated by some method. Unfortunately, homograft rejection
still occurs all too frequently, and
the toxicity of the drugs used presents problems. However, in other
animal systems the rejection process is directly related to the degree
of antigenic difference between the
donor and the recipient. Recently,
various transplantation centers have
tried to achieve antigenic similarity
between the donor and the recipient
as a means of improving the homograft survival rate. In order to do
this, the antigens of the potential
donors and the recipient are measured in vitro. This is called tissue
typing, or histocompatibility matching.
Humans have been shown to develop antibodies against donor cells
following multiple blood transfusions, multiple pregnancies, organ
homografting and deliberate immunization using repeated injections
of leukocytes or platelets. Such antibodies are cross-reactive in varying percentages of the random
population. A panel of such antibodies or antisera can be tested
against any individual's cells to determine his antigenicity. This can

* Presented at the Fortieth Annual
McGuire Lecture Series, October 31N ovember 1, 1968, Medical College
of Virginia, Richmond.
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then be compared with the results
of typing from other individuals
prior to transplantation.
Antibodies have been identified
against an antigen system known as
HL-A (Table 1) . Tissue typing
studies performed in families have
shown that this system is the result
of antigenic determinants present
on the same pair of chromosomes
at several subloci. However, the
exact interrelationship of these determinants is not fully known. The
use of the HL-A terminology for
the antigens has simplified the exchange of information in this field.
The original terminology of various investigators for these antigens
is also shown in Table 1.
Methods
The methods most commonly
employed in tissue typing are: 1)
lymphocytotoxicity; 2) leukoagglutination; 3) platelet complement
fixation; 4) mixed cell agglutination; 5) immune adherence; and
6) mixed lymphocyte culture. The
lymphocytotoxicity test is the most
commonly employed test and requires viable lymphocytes, a foreign complement source (generally,
rabbit complement), and a battery
of antisera. Cell death occurs if an
antigen-antibody-complement reaction takes place. The most common
method of detecting cell death is a
dye exclusion method. Whereas
dead cells imbibe the surrounding
fluid, including the dye, and appear larger and darker on the inverted phase microscope, living
cells with intact cell membranes
exclude the surrounding fluid and

dye. Terasaki and co-workers have
developed one form of this technique (Terasaki, Vredevoe and
Mickey, 1967; Mittal et al., 1968).
An alternate method of determining cell death is to preincubate the
lymphocytes with 5 1 Cr and then
determine the release of this isotope
as an indication of cell death (Rogentine and Plocinik, 1967).
Reproducibility of these tests is
good, with about a 3% error. However, the tests cannot be done with
cells other than lymphocytes, e.g. ,
kidney cells. An assumption is
made that lymphocytes react similarly to cells from transplantable
organs, i.e., kidney, heart. However, this may not be the case. The
need for viable lymphocytes to perform the test precludes the later
testing of cadaver donors unless the
lymphocytes are specially freezepreserved or maintained in tissue
culture. An outline of the lymphocytotoxicity test employed at the
Medical College of Virginia is
shown in Table 2.
Leukoagglutination is also a
commonly employed method of
tissue typing. In this method leukocytes (whole "huffy coat") are
reacted with the panel of antisera
without any complement (Zmijewski
et al., 1967). An antigen-antibody
reaction leads to agglutination of
the white blood cells. There are a
number of antibodies which are
more reactive in the leukoagglutination test than in the lymphocytotoxicity test, as well as several antibodies which are demonstrable only
by leukoagglutination. However,
these later antibodies presumably
MCV QUARTERLY 5(4): 190-194, 1969
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TABLE 1
Nomenclature of HL-A System Terminology of 3 Investigators
Dausset
HL-Al
HL-A2
HL-A3
HL-A5
HL-A7
HL-AS

van Rood

Payne

LAl
SA
LA3
DAS
7C
7D
4A
4B
4C

LAI
LA2
LA3

11

1 (MAC)
12
5
10

8

4D
7D

TABLE 2
Outline of Lymphocytotoxicity Test
1. Prepare pure suspension of lymphocytes
a. Freshly drawn specimen
b . Mailed specimen
2. Add lymphocytes to previously prepared trays of
110 antisera + recipient's sera
3. Add pooled rabbit complement
4. Add eosin and formalin
5. Allow cells to resettle and prepare trays for readings
6. Read microtest trays on inverted phase microscope
7. Evaluate typing

45 min

60 min
60-120 min
30 min
15 min
15 min
4-5 hr

MIXED AGGLUTINATION
Rh (D) • RBC

· w~ ~

ANTI~

GOAT
-.f
HUMAN lgG .-:;;__,_._

\~

[><ANTI

l~;G~NTIBOD'

id-- ~SERUM
~

KIDNEY

CELLS

Fig. 1-The mixed cell agglutination test. See text.

AB

are not recognizing important transplant antigens.
The platelet complement fixation
test requires platelets, complement,
and a battery of antisera (Shulman
et al., 1964). This test is no longer
widely employed. Dausset (1969)
recently described new antigenantibody reactions-related to the
HL-A system-which occurred with
this test but were not demonstrable
in the lymphocytotoxic or leukoagglutination tests.
All three of these tests require a
large panel of antisera. Whereas
erythrocyte typing requires only a
single anti-A serum and a single
anti-B serum. This is because the
transplantation antigens as well as
the antisera employed for detecting
these antigens are poorly defined.
The three other techniques of
tissue typing are not widely employed at present but may have
wider application in the future.
Mixed cell agglutination requires
that the target cells be grown in
tissue culture monolayers (Milgrom
et al., 1966). However, any cell
line capable of being grown in tissue culture may be used . Attempts
to employ this test with dispersed,
fresh cells, cryostat sections, or
fresh tissue slices have been unsuccessful. This test requires a special
indicator cell system consisting of
human erythocytes precoated with
an antibody directed against human
erythrocytes and an anti-human antibody capable of reacting with both
the first antibody and the test antisera. At the Medical College of
Virginia this indicator system consists of Rh+ erythrocytes precoated
with anti-Rh antibody and a goat
anti-human antibody. The test antiserum is layered over the monolayer of target cells, followed by
thorough washing and the addition
of the coated indicator cell system.
Agglutination of the indicator cell
system indicates that the test antiserum has reacted with the target
cell (Fig. 1) .
The immune adherence test requires a cell suspension, potent
complement source, and human
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erythrocytes (Nelson, 1956). It
can be performed with various
types of cells-dead or alive. If an
antigen-antibody-complement reaction takes place, the erythrocyte indicator cells will adhere to the target cell. The immune adherence
and mixed cell agglutination tests
are much more sensitive than the
previously described tests. The
mixed lymphocyte culture technique
has been described in full by Bach
(1966).
In the immune adherence test a
comparison of reactivity of lymphocytes and kidney cells from one
individual against the same antisera revealed these results in the
five individuals studied: 37 negative reactions against lymphocytes
and kidney cells, 15 positive reactions against lymphocytes and
kidney cells, 29 reactions in which
the antisera reacted positively with
kidney cells and negatively with
lymphocytes, and four instances in
which the reverse relationship
existed. This is presumptive evidence for an antigenic difference
between kidney cells and lymphocytes. Whether or not it is a qualitative or quantitative difference is
not shown by these data. At any
rate, the data are against the assumption that, by typing leukocytes, one can determine the full
antigenicity of an organ to be transplanted.
A similar discrepancy has been
demonstrated by testing lymphocytes and kidney cells from the
same individual-through use of
the lymphocytotoxicity and mixed
cell agglutination tests, respectively.
In retesting an individual's cells
against an antiserum in which the
lymphocytotoxicity reaction was
negative and the mixed cell agglutination reaction positive, the difference in reactivity appeared to be
quantitative, as prior absorption
with the individual's leukocytes removed the reactivity against kidney
cells, despite there originally being
no reactivity demonstrable by lymphocytotoxicity testing.
Since the antigenic determinants
192

TABLE 3
Examples of Lymphocyte Typing Results " A" Match
Example 1
HL-Al HL-A2 HL-A3 HL-A7
Donoc
+
+
+
Recipient
+
+
+
4 of 100 sera "killed" donor's but not recipient's cells

HL-AS

4A

+

+

4B

4C

+

+

Example 2
HL-AI HL-A2 HL-A3 HL-A7 HL-AS 4A 4B 4C
Donor
+
Recipient
+
+
+
+ +
1 of 100 sera "killed" donor's but not recipient's cells. All of above differences
in antigenic groups are in the "minor direction."

for the HL-A system occur on the
same pair of chromosomes, there
is a 25 % chance that a sibling will
be identical with any other sibling
for the HL-A system. By tissue typing a family, it can be determined
which individuals share 0, 1, or
both chromosomes. Amos et al.
( 1969) have shown that skin grafts
between nonimmunosuppressed siblings known to be identical for
the HL-A system have a mean survival of about 25 days. The failure
of permanent graft take might indicate that there are other antigenic
systems present on other chromosomes which are not yet defined.
Detailed absorption studies have
been done in our laboratory to
demonstrate the presence of HL-A
antigens in various human tissues,
i.e., kidney, liver, heart, blood vessels, lung, skin, pancreas, ureter
and fat. Kidney and liver tissue

were found to contain all eight of
the well recognized HL-A antigens,
whereas fat had no HL-A antigens.
The other tissues studied were not
tested for all eight antigen groups
but did contain every antigen for
which tests were run (Rolley, Williams and Hume, 1968). These
studies were sufficiently controlled
to exclude the possibilities of nonspecific loss of antibody activity
through surface absorption phenomena or by anti-complementary factors. The studies indicated that the
HL-A system is widely distributed
in human organs, but this does not
preclude the possibility that tissues
possess important histocompatibility antigens not detectable on leukocytes. The possibility of such tissue transplantation antigens being
poorly expressed on leukocytes has
been shown in the ABO erythrocyte system.

TISSUE TYPING

Histocompatibility Matching
Of the six tissue typing techniques discussed above, only mixed
lymphocyte culture involves direct
interaction between donor and recipient cells. The other five tests all
use a comparison of results against
a panel of antisera. A histocompatibility match may be reported on
an A, B, C, or D scale. The terms
A and B are comparable to the
terms matched or compatible; the
terms C and D are comparable to
the terms mismatched or incompatible. Table 3 shows two examples of an A match. In the upper
example of that table, the antigenicity of the donor and the recipient
for these eight antigens is the same.
However, a great deal of attention
is also given to individual serum
reactions, since not all sera have
been classified for one of these particular antigen groups. In this example 4% of the sera reacted
with antigens of the donor but not
of the recipient. Theoretically, the
recipient is capable of reacting to
such foreign antigens.

In the second example of an A
match in Table 3, the recipient bas
more antigen groups than the
donor. At our present level of
knowledge, this is assumed not to
affect graft survival and therefore,
the example is not considered a
mismatch; but rather an A match.
Table 4 shows an example of a
B match in which no recognized
antigen groups are present on donor
cells but absent on recipient cells.
However, more than 5 % of the
individual sera detected antigens on
donor but not recipient cells; hence,
this match is rated B rather than A.
Table 4 also shows an example
of a C match in which a well recognized antigen group is present on
donor cells but absent on recipient
cells. A D match (Table 4) indicates a donor-to-recipient mismatch
of two antigen groups.

auto-antibodies, such as the antiglomerular basement membrane
antibodies. To look for preformed
antibodies against histocompatibility antigens, it is necessary to perform a cross match test using the
recipient's serum and donor's cells.
This can be done by any one of
the five tissue typing methods discussed in this paper. If preformed
antibodies are found and a transplant performed, there is a great
probability that the transplant will
be rejected very quickly. A discussion of the detection of autoantibodies is beyond the scope of
this paper.
At present, bistocompatibility
matching is an inexact science, and
there are undoubtedly many histocompatibility antigens either poorly
defined or undefined. With further
definition of such antigens, improvement can be expected in the
correlation of tissue typing with
homograft function and survival.
Further work also needs to be done
to determine which method of tissue typing is best.

Preformed Antibodies
Tissue typing tests determine
neither the presence of preformed
antibodies against donor antigens,
nor the presence of organ-specific

TABLE 4
Examples of Lymphocyte Typing Results
HL-Al

HL-A2

"B" Match
HL-A3
HL-A7

+
+
Donor
Recipient
+
+
12 of 100 sera "killed" donor's but not recipient's sera.

Donor
Recipient

---I HL-A l

l

HL-AS

4A

4B

4C

HL-A8

4A

4B

4C

+
+
"C" Match

HL-A2

HL-A3

HL-A7

+
+

+

+
+

+
+

1 group mismatch in "major direction."
"D" Match
HL-Al
Donor
Recipient

ff

2 group mismatches in "major direction."

HL-A3

+
+

ITJ

HL-AS

4A

+
+

4B

4C

+
+
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Relation of Tissue Typing to Results of
Clinical Transplants*
HYUNG M. LEE

Department of Surgery, Medical College of Virginia, Richmond 23219

The theoretical background for
tissue typing has already been given
to us by Dr. Bach with his usual
simplicity and clarity. Methods currently in use have been described
by Dr. Rolley. In the following
brief article I will report on the
correlations that we and other
groups have seen between tissue
matching and the results of clinical
transplants.
Tables 1 and 2 show the terms
we use relating to the clinical ranking of the course and the tissue
matching grade.

because of the possibility of recurrence of the original disease which
may not be within the framework
of histocompatibility tissue matching. An interesting point to note
is that in the group of patients
whose tissue typing grade is C, i.e.,
only one major group mismatches,
there is a fairly even spread between those whose clinical course
is good and those whose clinical

course is poor. Similar results have
been observed by others, particularly Dr. Terasaki, who compiled
fairly large numbers from multiple
centers.
Chi-square analysis of the distribution of 2 X 2 tables is given in
Table 4 with the AB group as a
match and CD group as a mismatch. The distribution falls short
of statistical significance with a p

TABLE 1
Evaluation of Donor-Recipient Histocompatibility Testing Grade

Living Related Donors

A- Less than 5% major mismatches and no major group mismatches
In spite of the technical difficulties and the many variables involved in clinical transplantation,
correlation of the tissue matching
with living related donor transplants has been shown to be reasonably good (Vredevoe et al.,
1965; Terasaki et al .., 1966; Lee et
al., 1967). Table 3 shows a retrospective study of the living related
donor patients in Richmond who
survived at least six months. Since
it is a retrospective study and does
not include acute failure, it is not
a pure study of the statistical evaluations; however, quite a significant
clinical trend can be seen. Patients
who had good tissue matching almost always appeared to have had a
good clinical course, though there
were a few exceptions. These exceptions themselves are interesting

* Presented at the Fortieth Annual
McGuire Lecture Series, October 31November 1, 1968, Medical College
of Virginia, Richmond.
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B- More than 5% major mismatches and no definite major group mismatches
C- One major group mismatch with less than 25% major mismatches
D- Two major group mismatches OR more than 25% major mismatches

TABLE 2
Results of Kidney Homotransplants
Clinical grades
Serum
Creatinine

BUN

Creatinine
Clearance

Proteinuria

Blood Pressure

<20

770

0

Normal

A

<1.5

B

1.5- 2.0

20-40

70-40

+

Controlled without
Medication

c

2.0-3.0

<100

40-20

++

Controlled with
Medication

+++or>

Difficult to
Control
Medication

D

>3.0

>100

<20
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TABLE 3
Correlation of Clinical Results and Histocompatibility Typing
Clinical Rank

I

Lymphocyte
Antigen
Matching

I

A

c

B

D.L. *
M.H.
F. C.

I

K.G.
B. L.
F. C.

M.P.
J.M.

w. F.

A

D

I

N. McC.
E. P.
R.M.
- --

----

J. We.
G.M.

D.P.

R. R.
N.McE.

w. c.
B

R. C.
R. A.
R. E.
c. J.
L. D.
J.M.
L. v.
E. J.
H.B.

c

E. A.
J. DeR.
R.G .
G.F.
O.L.
N.R.
R. P.
M. H.
J. w.
S.H.

c. 0.
K.R .

D

M.D.
E. R.
R. A.
B. C.
S.S.

W. T.

W. P.

I

w. L.
P.M.
V. M

E.R.
J. L.
W.J.

I

I
* Tnitials refer to patients' names.

-----

value of 0.14. However, if one divides and separates clinical rank A
from the remaining B, C, D , a statistically significant distribution with
a p value of 0.005 is noted (Table
5) . This means that the majority
of poor clinical results belong to
the mismatch group, and most of
the patients who matched well belong to the group with a good clinical outcome. The other point is
that, of the group whose matching
grade is C, almost half of them have
done quite well in spite of mismatch. This spread of results has
been explained (in speculation) by
mistyping due to technical difficulties, incomplete antigen panels,
variability of the effectiveness of
immunosuppression on different patients, and the variability of responsiveness of different patients.
Patients doing well who received
a mismatched transplant would
have been missed if typing had been
used for selection. In comparing
the group of patients having siblingto-sibling relationships with the
group having parent-to-child relationships, Singal, Mickey and Terasaki ( 1969) noted that there is a
higher correlation with the sibling
group (Table 6) . This is not surprising when one considers the
probable ease with which the genetic similarity can be defined
among the siblings. Dr. Bach has
already enlightened us on this
aspect.
Unrelated Cadaver Donors

TABLE 4
Correlation of Histocompatibility
Typing with Clinical Course
(Living related, Richmond,
October, 1968)
Good
Matched
Mismatched

18
19

Total- 52
p

196

< 0.14

Poor
4
11

TABLE 5
Correlation of Tissue Matching with
Clinical Course

15

BCD
8

8

22

A

Matched
Mismatched
p

< 0.005

Since tissue typing has neither
been done very long nor very frequently on the cadaver donor series,
we do not as yet have a good statistical study. However, some of the
results are beginning to come in . Dr.
Terasaki's recent review of the results, based on data from many
centers, seems to show some correlation, though not as clearly nor as
significantly as among living related donor groups (Patel, Mickey
and Terasaki, 1968) . Table 7 shows
these results. He also found some
significance when he compared re-

TISSUE TYPING AND CLIN ICAL TRANSPLANTS

TABLE 6

Correlation of Clinical Rank and Typing in Patients with More Than 6 Months
Graft Survival
Clinical rank
B

c

D

35

7

4

12
25
25

9

Relationship

A

Matched
Mismatched
Matched
Mismatched

Sib-Sib*
Parent-Childt

13
13

F

Total

0

2

48

2

11
2

34
43

11

63

13

* Sib-Sib: Matched vs Mismatched t = 3.66; p < .001
t Parent-Child: Matched vs Mismatched t = 2.54; p = .01
Data from Singal, Mickey and Terasaki (1969).

TABLE 7

TABLE 8

Clinical Rank and Typing
(Over 4 months survival)

Correlation of Rejection and Tissue
Matching

Matched
Mismatched
p

A

s

c

D

6

10

1

0

4

14

7

3 13

<

0.02

1

F
4

Matched
Mismatched

Data from Patel, Mickey and
Terasaki (1968).

A
9

B

c

8

6

D
3

19

21

4
8
p < 0 .001

Data from Patel, Mickey and
Terasaki (1968).

TABLE 9

Creatinine Clearance and Tissue Typing

Donor
Matched

NR*

ct
Mismatched

NR

c

Cadaver Matched vs Mismatched p

< 0.01

* Nonrelated
t Cadaver
Data from Patel, Mickey and Terasaki (1968).

Creatinine
Clearance

Mean

88.0
74.2

78.5

69.6
44.7

50. l

jection types with tissue matching
(Table 8). When he compared
renal function, he also found a
fairly significant difference in creatinine clearance between the matched
group and the mismatched group
in cadaver transplant patients (Table 9). The p value in the matched
cadaver versus the mismatched
cadaver source was 0.01. Two
other groups have reported their
experiences, though on rather small
numbers (Morris, Kincaid-Smith
and Marshall, 1969; van Rood et
al., 1969). Both of these groups
have found significant statistical
correlations of typing and clinical
results in unrelated donor-recipient
pairs (Tables 10 and 11).
Our cadaver typing results have
been rather small in number, so although we cannot attribute any statistical significance to the results,
they are of some interest. Table 12
shows the following prospective
study. Among the seven patients
whose clinical results were poor in
the matched group, four, in a subsequent study, had a positive cross
match against the donors' kidney
cells. Even though the numbers are
small and the period of observation
short, an encouraging trend can be
seen.
We have attempted to show that
a correlation exists between the results of tissue typing as practiced
using leukocyte group antigens, the
HL-A system, and the outcome of
renal homotransplantation. We, as
well as Dr. Bach, agree that the
correlation is not as close as one
would wish and is particularly low
with unrelated cadaver donor
source. To make matters more
complicated and difficult, there is
the problem of ABO system histocompatibilities. The detrimental influence of the ABO group incompatibility upon the clinical result
of the human renal homotransplant
has been well substantiated (Starzl
et al., 1963 ; Hume et al., 1964;
Starzl, 1964; Gleason and Murray,
1967).
There is evidence that preexisting host anti-donor antibodies,
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TABLE 10
Correlation of Leukocyte Typing of Unrelated Donor-Recipient Pairs and
Rejection Grade After Renal Transplantation
Rejection grade
A

Matched

B

2

v4

Mismatched

I

x'

v4
=

2

3

4.9

c

checked by a cross match test of
donor's leukocytes and recipient's
serum, appear to play a significant
role in "hyperacute rejection" of
the renal homotransplant (Terasaki,
Thrasher and Hauber, 1968; Williams et al., 1968).

D
I

vI

6

v18

p

0

12

< 0 .05

Data from Morris, Kincaid-Smith and Marshall (1969).

Summary

Current data reveal that, when
matching is very good, there is also
very good correlation in living related donor results, particularly in
the sibling donor source. When
there is slight mismatching, correlation is not as good; however,
many patients seem to do well in
spite of some mismatch. Correlation
in the unrelated cadaver group is
not as precise or significant.
The current status of tissue typing is still not as precise as it
should be, in order for us to rely on
it as a selection criterion for renal
homotransplantation. However,
with rapidly advancing knowledge
of antigen groups in the HL-A system and a more refined and simplified method of tissue typing, the
significance of the correlation between tissue typing and clinical results of the homotransplant should
improve.

TABLE 12
Unrelated Cadaver Donor Source
(Richmond, 1969)
Typing
Clinical course

TABLE 11
Correlation of Leukocyte Typing of Unrelated Donor-Recipient Paris and Renal
Homograft Survival

3 Functioning

# of Cases

~1

~%

~3

W%

4 or more

303

8
12
17

HL-A Mismatched

p

Data from van Rood et al. (1969).
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< 0.02

Matched

8

Poor
7*

Mismatched

2

4

Good

* 2- long ischemia, pretransplant;
I- died from hepatic failure and
gastrointestinal hemorrhage; 4positive cross match between
donor lymphocyte or kidney
cells and recipient serum.
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Cellular Rejection*
JAMES S. WOLF

Division of McGuire Veterans Administration Hospital Surgery,
Department of Surgery, Medical College of Virginia, Richmond 23219

Introduction and Background

Delayed or cellular hypersensitivity is the primary immunologic
mechanism in the rejection of
organ homografts. Mounting evidence implicates the small lymphocyte as the cell responsible for implementing this reaction.
The immunologic role of the
lymphocyte in the graft-versus-host
reaction was first recognized by Simonsen (1957). He showed that if
newborn or heavily irradiated mice
are injected with foreign adult lymphoid cells, the animals will waste
and die. He further demonstrated
that the cells causing the graftversus-host reaction are present in
the peripheral blood of the mouse.
Other investigators have since demonstrated that this cell is the small
lymphocyte.
Strober and Gowans (1965)
have demonstrated that there is interaction between small lymphocytes and a foreign organ graft.
In this study, lymphocytes were
first perfused through isolated allogenic kidneys and then injected
back into the animal from which
the lymphocytes were derived. It
could then be demonstrated that
these animals reacted to a skin
graft from the kidney donor with
a secondary response, indicating
prior sensitization. This study
seemed to indicate that the small
lymphocyte is involved in the af-

* Presented at the Fortieth Annual
McGuire Lecture Series, October 31November 1, 1968, Medical College
of Virginia, Richmond.
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ferent (sensitization) limb of the
homograft response.
There is also experimental evidence to suggest that the small
lymphocyte is intimately involved
in the efferent (destruction) limb
of the homograft response. The
earliest indication of this was histologic interpretation of the events
surrounding the homograft reaction. In serial biopsies taken daily
following renal transplantation in
dogs, the events can be examined
unmodified by immunosuppressive
agents. In biopsies from such dogs,
very little histologic alteration can
be seen for the first 48 hours, but
by the third day there are wellestablished pyronine-positive mononuclear cells in the perivascular interstitial areas. In the ensuing days
this infiltration spreads and tubular
cell degeneration occurs, followed
by infarction. The glomeruli remain
remarkably normal during this entire process of primary graft rejection. In the immunosuppressed
animal this perivascular infiltration
of immunocytes does not occur,
and organ function is prolonged .
Experimental Data

Interested in this observed phenomenon, my colleagues and I designed several experiments to study
the relationships of the lymphocyte
to the efferent arc of transplant
immunity and the effect of lymphocyte depletion upon the temporal and histologic events of the
homograft response.
Because of the marked radiosensitivity of the lymphocyte, it seemed

possible that lymphocyte depletion
could be produced in the experimental animal by the use of radiation. Hume and Egdahl (Hume et
al., 1960) had previously reported
that lethal whole-body radiation in
the dog abrogated the immune response, whereas sublethal doses of
radiation did not alter the immune
response.
Our first experiments (Wolf et
al., 1966) utilized small pellets of
Yttrium9o, a powerful beta emitter
having a half-life of 64 hours. The
pellets were encased in Silastic tubing and implanted into the abdominal aortas of dogs. Thus, all the
blood flowing through the aorta
was irradiated. These animals all
showed a prompt and profound
lymphopenia (Fig. 1), which persisted for two to three weeks following the cessation of radiation
and dropped to levels of 10 % of
control values.
Serial biopsies of mesenteric
lymph nodes in these animals
showed progressive lymphocyte de- ·
pletion from germinal follicles. Bizarre cells were seen in the circulating blood of these animals during the radiation period; the cells
showed clumping of the cytoplasm
and nuclear vacuolization.
A group of these animals received renal homografts in addition
to blood irradiation (Fig. 2). The
untreated control kidneys had a
functional survival of 5.2 days,
while the irradiated animals had
a mean functional survival of 16
days, the longest functional survival being 34 days. From this
study, it appeared that a relationMCV QUARTERLY 5(4): 200-203 , 1969
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Fig. 1- Dogs receiving Y90 implants show a marked and prolonged lymphocytopenia.

ship existed between total lymphocyte mass in the dog and its
ability to produce homograft destruction.
To examine further the effect of
the lymphocyte on the efferent arc,
we designed an experiment in
which we tried to keep the afferent
arc constant (Wolf, McGavic and
Hume, 1969) . To do this, we simultaneously transplanted two kidneys from the same donor into the
same recipient. One kidney was
placed in the pelvis and the other
in the neck. One of the two kidneys received local graft irradiation
in a dose of 150 roentgens on days
one, three, five and seven post
transplantation. Thus, the animal
had one kidney to which he was
normally sensitized and which had
received no form of immunosup-
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Fig. 2.-Dogs receiving y 9o radiation concurrent with renal transplantation have
prolonged homograph survival.
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pression, while the other kidney
received only local graft irradiation. Serial biopsies were then taken
simultaneously in both kidneys in
several dogs. In each biopsy the
unirradiated kidney showed more
marked cellular infiltration on any
given day than the irradiated kidney. The nonirradiated kidneys rejected in a mean time of 5.7 days,
while the irradiated kidneys had a
mean survival time of 12.1 days,
with 24 days the longest period for
a surviving kidney.
It would appear from this experiment that the animal was normally
sensitized-as indicated by rejection in the normal time of the untreated kidney- but that the local
irradiation served as an immunosuppressant, probably by destroying sensitized lymphocytes in the
kidney. This experiment, then, gives
further evidence that the lympho-

cyte is involved in the primary immune response.
To further manipulate the cellular environment in an attempt to
study the effect of the lymphocyte
on the efferent arc of transplant
immunity, we designed some tissue culture experiments (Wolf,
Fawley and Hume, 1969) . In these
studies, renal cells were cultured
from transplanted kidneys removed
from patients who had rejected
either chronically or acutely. These
cells were grown in tissue culture
at 37C, using Eagle's Minimum Essential Medium to which was added
20 % serum and penicillin, streptomycin, and L-glutamine. After
these monolayer cultures had been
established for a period of five to
seven days, lymphocytes-from the
patient, from the kidney donor, or
from an indifferent donor-were
added to the cultures. Figure 3

shows one such renal cell monolayer culture to which indifferent
lymphocytes have been added.
The lymphocytes did not appear to
have any effect on the cultures,
and the culture continued to grow
in a normal fashion. However, as
seen in Figure 4, when the patient's
own lymphocytes were added to the
culture, even in the absence of
complement or autologous serum,
there was destruction of most of the
kidney monolayer within 12 to 14
hours. Nine human kidneys which
had been previously transplanted
for periods of 1 to 18 months have
thus far been studied, as have been
six non-transplanted kidneys. In
seven of the nine transplanted kidneys which had histologically established rejection patterns, the recipients' lymphocytes were markedly
cytotoxic to the kidney cells, showing destruction of most of the mo-

Fig. 3-Renal cell monolayer culture reacted with indifferent lymphocytes and showing no evidence of renal cell destruction (X 380).
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Fig. 4-Renal cell culture reacted with specifically sensitized lymphocytes and showing marked renal cell destruction
( X 380).

nolayer within 12 to 14 hours, even
in the absence of complement
source and regardless of the source
of the serum. Indifferent lymphocytes, donor lymphocytes, or lymphocytes from other transplant recipients did not h ave this same
effect.
Conclusion
From these studies we have concluded that : 1) sensitized lymphocytes in close physical contact to
the target cell can produce destruction of the target cell; 2) deficiency
of lymphoid mass within the organ
homograft recipient can produce
attenuation of the homograft reaction; and 3) the lymphocyte target
cell reaction in vitro is individua lspecific, but not complementdependent, is rapid, and proceeds in
the absence of autologous serum
source.

Mounting experimental data suggest that the homograft reaction
is intimately related to the small
lymphocyte. It is evident th at both
the afferent and efferent arcs of
transplant immunity are dependent
upon the intactness of the lymphoid system. The lymphocyte has
the ability to recognize the foreign
antigen, is involved in the activity
of cell-bound antibodies, and m ay
be involved in the inductive processes leading to antibody form ation.
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leukocyte group in tissue typing, 196198;
tissue typing (histocompatibility testing), 190-193
Anxiety:
and promotion of disorganization,
116- 118;
as psychiatric emergency, 107;
in surgical patient, 13 5
Arabinose:
L-arabinose utilization in Escherichia
coli (abstract), 33

Arachnida:
sex-determining mechanisms in (abstract), 35-36
Attitude:
in prejudice, 91-92
B
Bacteriophage:
neutralization of, 10
Behavior:
assessment of normal, in humans,
147-150;
deviant, in humans, 85-89;
emotional reactions of surgical patient,
135-136;
in psychiatric emergencies, 107-109;
treatment of disorders in, 120-124
Behavioral sciences:
ideal characteristics of scientists, 87
Benemid. See Probenecid
Birds:
immunoelectrophoretic analysis of
proteins of House Sparrow (abstract), 37-38
Bone resorption:
and osteopetrosis, 17- 19
Body temperature:
radio-frequency electrodes and hyperthermia, 23
Body temperature regulation:
instrumentation, 20-26;
methods and theories of brain heating
and cooling, 20-26
Brain:
temperature-sensitive areas in, 23-24

c
Carbon monoxide poisoning:
in Great Britain, 53-55
Carinamide. See Uricosuric agents
Catecholamines:
relationship to thyroid hormone, 46
Central nervous system:
thermal stimulation of, 24
Chemotherapy. See Drug therapy
Child welfare:
history of, 91-92
Chromatography:
DEAE-cellulose, 12
Cinchophen:
use in gout, 7
Cyclic 3', 5'-AMP:
in sodium permeability (abstract), 38
Cognition:
effects of stress on, in surgical patient,
135-136
Cognition disorders:
as psychiatric emergencies, 107
Colchicum:
use in gout, 5
Communication:
interprofessional and patient relationships, 93-110
teaching as major contribution of psychiatrist, 103
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Community health services:
and interprofessional relations, 143146
Community mental health services:
importance of, in psychiatric therapy,
120--124
scarcity of, 145
Complement fixation tests:
in tissue typing, 190--191
Computers:
in medicine (book review), 77
Contact lenses:
and unilateral aphakia, 69-71;
obstacles to fitting of aphakic patients,
71
Counseling:
for sexual problems, 130- 134
Creatinine:
clearance and tissue typing, 197
Culture:
influence on the individual, 92
Curriculum:
in medical schools, 120
Cyclophosphamide:
effects on normal and induced immune
responses, 10--11
Cytogenetics:
in the Acarina (abstract), 35-36
D

Dactinomycin:
effects on normal and induced immune
response, 10
Death:
by accidental carbon monoxide poisoning, 53-55. See also Suicide
Decision making:
operations research in, 62-65
Defense mechanisms:
in parental response to child illness,
116- 119;
in surgical patients, 135-136
Delusions:
drug therapy for, 152, 153-154
Depression:
in the elderly, 140
Disease:
as form of deviance, 85-89;
interaction of family and physician in,
116-119
Drug addiction:
in treatment of psychiatric disorders,
154-155
DNA:
in antibody specificity control, 9
Drosophila:
equinoxialis, mating pattern of (abstract), 34
Drug therapy:
in gout, 5-8;
in psychiatric disorders, 151-160;
in psychiatric emergencies, 108-109;
in senile dementia, 139-140;
in treatment of transplant rejection,
167-168
Drug tolerance:
in treatment of psychiatric disorders,
153-159
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E

Emergencies:
psychiatric, recognition of, 106;
psychiatric, treatment of, 108- 110
Environment:
human and early influences of, 90-92;
importance of adaptation to, 86-89;
relationship to treatment of psychological disturbances, 120--121
Epinephrine:
influence on ion exchange (abstract),
38
Epithelium:
cells of, in anaerobic utilization of
L-lactate (abstract), 36- 37
Escherichia coli:
L-arabinose utilization in (abstract),
33
F

Family:
as factor in psychophysiologic disorders, 112-115;
influence on individual psychlogy,
122- 124
Family therapy:
in medical practice, 111-124;
in mental illness, 122-124;
in therapeutic abortion, 128;
role of physician in, during illness,
116- 119
Frogs:
acid-base behavior and ion fluxes in
(abstract), 34;
muscles, contraction of (abstract), 36;
sodium permeability of skin (abstract),
38

G
Gamma globulin:
and onset of the immune response,
9- 15
Geriatrics:
effects of disease and treatment on
older population, 137-141
Gingiva:
anaerobic streptococci indigenous to
(abstract), 37
Gout:
classification and pathology of, 3-5;
etiology of, 2-3;
therapy in, 5-7
Guilt:
and promotion of disorganization,
116- 119
H

Hallucinogens:
experimental use in treatment of depression, 153
Health:
concepts of, 85-87, 89
HeLa cells:
induction of fusion in (abstract), 33
Histamine:
in thyroid hormone function, 44-48
Histological technics:
relation to clinical transplants, 195196

Hospital psychiatric departments:
functions of, 104-105;
significance of, to medical practice,
112- 115
Hyperbaric oxygenation:
in organ preservation, 171, 175-17 6
Hypercalcemia:
as related to osteopetrosis, 17- 19
Hyperthyroidism:
physiopathology of, 45
Hypocalcemia:
as related to osteopetrosis, 17-18
Hypochondriasis:
in the elderly, 140
Hypoparathyroidism:
as explanation for osteopetrosis, 17
Hypothalamus:
and brain temperature, 20-26
Hypothermia:
and circulating liquid thermodes,
20-21
Hypothermia, induced:
in organ preservation, 171-172
Hypothyroidism:
vascular responsiveness in, 46
I

Immune serums:
activity of, 10--15;
induction of tolerance to tissue allografts, 182
Immune tolerance:
actively acquired, 182-183
relation to antilymphocyte serum,
184- 188
Immunoelectrophoresis:
in egg white, yolk and plasma protein
analysis (abstract), 37-38
Immunology:
defense mechanisms and infection,
49-52;
onset of immune response, 9-15
lmmunosuppressive agents:
complications of, 182
influence on graft-versus-host reactions, 183-188
lndomethacin:
use in gout, 6
Ion exchange:
in frog skin (abstract), 34, 38
Infection:
mechanisms against, 49-52
Institutional practice:
role of state hospital in care of mentally ill, 121- 122
Interprofessional relations:
and patient anxiety, 94;
attitudinal differences between physician and psychiatrist, 101-102
in assessing normal behavior, 147150
in health professions, 143-146
in psychiatric emergencies, 106;
planning for and evaluation of, 143146
referring physician and the psychiatrist, 101-105

Isolation perfusion:
physiology and application of, in organs, 173-181
systems, 17 3-17 4

J
Judgment:
moral, in determination of deviant
behavior, 86-89
K
Kidney:
preservation of, 171
L
Lactates:
anaerobic utilization of (abstract), 3637
Learning:
and human development, 90-91
Legislation, medical:
concerning abortion, 126- 129
Lymphocytes:
and transplantation cellular immunity, 49-52;
effect of depletion on homograft response, 200-201
immunologic role of, 200
Lymphoid tissue:
and immune capability, 184

M
Mental disorders:
drug therapy in, 151- 160
Mental health:
concepts of, 86-87;
prevention of psychiatric emergencies,
110
Mercaptoethanol:
in early and late antibody differentiation. 12
Metabolic clearance rate:
in organ preservation, 171-172
Monkeys:
Macaca mulatta, intrinsic back musculature of (abstract), 35
Mosaicism:
erythrocyte chimerism in cattle twins,
182-183
Muscle contraction:
in frogs (abstract), 36
Muscles:
spinal, classification of (abstract), 35
Mutation:
enhancement of L-arabinose utilization in Escherichia coli by (abstract), 33
N
Nephrocalcinosis:
as related to osteopetrosis, 17
Neural transmission:
classification of chemical media, 27
Neurohormones. See Neurohumors
Neurohumors:
as chemical mediators, 27- 30;
as distinguished from neurohormones,
27
Neurons:
as neurosecretory cells, 27-30

Neurosecretory cells. See Neurons
Neuroses:
psychoneurotic reactions in adults,
140-141
Neutralization tests:
phage-neutralization assay, 10
Noradrenaline. See Norepinephrine
Norepinephrine:
as messenger substance, 27;
in cold adaptation, 45
0
Operations research:
dynamic programming, 62;
linear programming in, 62;
methods of and use in university hospital, 61-68;
network analysis, 65
Osteoblasts:
activity in osteopetrosis, 18
Osteoclasts:
activity in osteopetrosis, 18
Osteogenesis:
and osteopetrosis, 18- 19
Osteopetrosis:
pathology of congenital and chemically induced, 17- 19
Oxygen consumption:
in frog muscles (abstract), 3 6
Oxytocin:
in direct action on "target" tissue, 29
p

Paleontology:
evaluation of Australopithecus and
other fossil types, 57-58;
use in determining earliest known
man, 56-59
Para-influenza viruses:
induction of fusion in cultured cells
by para-influenza 3 virus (abstract),
33
Parathyroid hormone:
use in osteopetrotic studies, 17-19
Passer domesticus. See Birds
Patients:
handling emotional reactions to surgery, 135- 136;
the older population as, 137-141
Perceptual disorders:
drug therapy in, 152
Perfusion:
importance of perfusate choice,
176-177;
in organ preservation, 171- 172
Peripheral nerves:
Schmidt-Lanterman incisures in (abstract), 32
Phagocytosis:
as defense in infectious disease, 49-51
Phenylbutazone:
use in gout, 6
Physician-patient relations:
and anxiety, 94-95
Physicians:
and sexual counseling, 130-134;
role in assessing normal behavior,
147-150

Plasma proteins:
immonoelectrophoretic analysis of
(abstract), 37-38
Population:
characteristics of the older, 137;
vital statistics of older, 137-140
Postoperative care:
in cardiac transplantation, 169
Preservation, biological:
advantages and disadvantages of, in
clinical transplantation, 171-172
methods of, for organs, 171-172
Probability:
stochastic programming in operations
research, 62
Probenecid:
use in gout, 7
Professional-patient relations:
in management of psychiatric emergencies, 108-110
Pro line:
tritiated, use in osteogenic evaluation,
18
Psychiatry:
in medical practice, 84-164;
in society and the community, 120124;
revolution in, 122-123;
trends in, 147-150
Psychopharmacology:
in development of psychiatric treatment, 151-159
Psychophysiologic disorders:
and family tension, 112- 115;
treatment of, 112-115
Psychophysiology:
in medical practice, 125-141
Psychoses:
as psychiatric emergencies, 107
Psychoses, senile:
concepts of etiology and treatment.
139-140
Psychosexual development:
factors in, 130-131
Psychotherapy:
in medical practice, 142-160;
management of, 104-105
Public opinion:
and treatment of deviants, 87-88
R

Rabbits:
in osteopetrotic studies, 18
Radio-frequency heating. See Body
temperature regulation
Referral and consultation:
choice of patient for, 94-95;
consultation methods, 102- 104;
in psychiatric emergencies, 107- 110;
preparation of patient for, 99-100;
problems in, 94- 100;
role of the psychiatrist, 101-104
Regeneration:
in immunologically competent cells,
186-187
RNA, messenger:
in mediation of antibody specificity
synthesis, 9
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s
Schools, medical:
Medical College of Virginia, history,
72-76
Serology:
studies and homotransplantation,
195-198
Serums. See Immune serums
Sex:
factors determining sexual identity,
130-131;
problems, 131-132
Sex behavior:
factors in, 13 0
Sex behavior, animal:
in Drosophila equinoxialis (abstract),
34
Social change:
as catalyst in interprofessional relations, 143-145
Social isolation:
of mentally ill, 121-122
Social problems:
and therapeutic abortion, 127-129
Social service, psychiatric:
role in psychophysiologic therapy,
114-115
Sociopathic personality:
drug therapy for, 152
Sodium:
transport across frog skin (abstract),
38
Sodium salicylate:
use in gout, 7
Steroids:
use in gout, 6
Streptococcus:
anaerobic, isolated from human subgingival crevice area (abstract), 37
Stress:
anxiety-defense model in surgical patient, 135
Suicide:
by carbon monoxide poisoning, 53;
risk of, in pregnant women, 126-127
Sulfonamides:
physicochemical properties of, in relation to biological activity (abstract), 32
Surgery, operative:
technique in cardiac transplantation,
169
Synapses:
conventional mode of communication,
27;
ultrastructural attributes of chemical,
27

T
Thermodes. See Body temperature regulation, 20-26
Thymectomy:
and induction of immune incompetence, 184-185
Thyrocalcitonin:
effects on bone formation 18
Thyroid gland:
'
role in osteopetrosis, 17
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Thyroid hormones:
physiology of, 44-48
Tissue donors:
methods of tissue typing, 190
Tobacco mosaic virus:
mechanical breakage of (abstract),
35
Tranquilizing agents:
neuroleptic and anxiolytic sedatives, 153-158;
therapeutic applications in psychiatric disorders, 153-158
Transplantation:
graft-versus-host reactions, 183-184
Transplantation, homologous:
and tissue typing, 190-198
cardiac, current status and future
potential of, 198;
cardiac, selection of patients for, 168169
detection and treatment of rejection,
169-170
rejection of homograft, 190
Transplantation immunology:
mechanisms of, 200-203

u
Uracil mustard:
effects on normal and induced immune
response, 10
Uric acid:
in gout, 7
Uricosuric agents:
use in gout, 7

v
Vasopressin:
in direct action on "target" tissue, 29
Vision:
binocular testing, 69-71;
unilateral aphakia and contact lenses,
69-71

w
Wine:
relationship to occurrence of gout,
7-8
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the "spasm reactor" in your practice

The Machine Age man still possesses a Stone Age stomach; sometimes the job of merely coping with today's
environmental stress may prove too much. For some
(the "spasm reactors" in your practice), tension, anxiety and worry may find expression through the voice of
gastrointestinal or other smooth muscle spasm. To treat
these patients with antispasmodics alone is often to
miss the point of origin of their disturbance; to rely
solely on tranquilizers often proves discouragingly slow
or ineffective in relieving spasm and pain.
To quiet and quell Donnatal can promptly and effectively quell the spasm and quiet the tensions that trigger
it. Prescribed by more physicians tha:ri any other antispasmodic-sedative, Donnatal continues to provide the
classic answer.
The "Donnatal Effect" The characteristic, over-all
effect of Donnatal has been observed in many thousands
of children and adults, clearly establishing its value as
a versatile sedative-antispasmodic. Outstanding in effectiveness, safety, economy, uniformity of composition
and dosage convenience, Donnatal continues to be desired and prescribed by a majority of physicians.

when the
'~ut issues"
get to him
he deserves

In a multiplicity of indications Particularly useful
when anxiety and tension accompany, aggravate or account for smooth muscle spasm, Donnatal is indicated
for the symptomatic relief of recurring, persistent or
chronic visceral spasm.

Brief summary Blurring of vision, dry mouth, difficult urination, and flushing or dryness of the skin may
occur on higher dosage levels, rarely on usual dosage.
Administer with caution to patients with incipient glaucoma or urinary bladder neck obstruction. Contraindicated in acute glaucoma, advanced renal or hepatic
disease or a hypersensitivity to any of the ingredients.
each tablet, capsule or
each
5cc. of elixir (23% alcohol)
Extentab®
hyoscyamine sulfate ................ 0.1037 mg.
0.3111 mg.
atrop.ine sulfate ........................ 0.0194 mg.
0.0582 mg.
hyoscine hydrobromide ............ 0.0065 mg.
0.0195 mg.
phenobarbital .................... ( 14 gr.) 16.2 mg.
( % gr.) 48.6 mg.
(warning: may be habit forming)

e
'tJonnatal®
~·~

......

~Hect''

QUIETS THE STRESS I QUELLS THE SPASM

A."· ROBINS COMPANY, RICHMO ND, VIRGI NIA A·H·ROBINS

